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Abstract 
 
 
Proteins perform their functions as part of multi-protein complexes. These protein 
complexes are vital for carrying out and regulating cellular processes. As such, there is a 
need for tools to measure protein-protein interaction (PPI) affinity, stoichiometry, and 
inhibition in order to map interaction sites and screen for PPI modulators. Such 
measurements can be challenging because PPIs can span a wide range of affinities and 
stoichiometries. While many techniques exist for PPI analysis they often require large 
amounts of protein, have relatively low throughput, or have utility among a narrow range 
of PPIs. 
Capillary electrophoresis (CE) has demonstrated utility for determination of PPI 
affinity and for screening of PPI modulators. CE has a number of advantages in PPI 
analysis including low sample volume requirements, direct detection of complexes, and 
the potential for high-throughput. However, method development for analysis of PPIs by 
CE is often hampered by the need to maintain the native interaction during the separation 
and prevent protein adsorption to the capillary wall. Here protein cross-linking capillary 
electrophoresis (PXCE) is reported and described. Covalently cross-linking interacting 
proteins prior to electrophoresis eliminates the need to maintain the native interaction 
during the separation, facilitating method development. The PXCE method is 
demonstrated for an antibody-antigen interaction and heterodimer and homodimer heat 
	 xvi	
shock protein complexes. Separation of free protein from protein complex is achieved 
either by using capillary zone electrophoresis or by capillary gel electrophoresis. PXCE is 
demonstrated to give quantitative results for PPI affinity and inhibition.  
Next, we expanded the utility of PXCE to access a wide range of PPIs including 
weak and multimeric oligomers. A short cross-linking reaction time of 10 s is found to 
have sufficient yields for a variety of complexes. Factors influencing non-specific cross-
linking are also explored with concentrations of protein >20 µM yielding non-specific 
complexes. Apparent dissociation constants for seven different PPIs spanning from low 
nanomolar to low micromolar are presented. Good agreement was found to non-cross-
linking methods. Assays of point mutations in the protein interaction site and nucleotide 
state dependence of association are also presented. Protein complexes less than about 250 
kDa are accessible using the presented method. Separation time is also reduced to about 1 
min/sample. 
Finally, a method for increasing the throughput of sample analysis is presented. 
Here, a microchip gel electrophoresis separation allowed for protein separation in 2.5 s. 
Further, a novel device for removing oil from segmented droplet flow based on density is 
demonstrated for coupling nanoliter-scale sample droplets to microchip separation for 
rapid and automated sample analysis. Throughputs of 10 s per sample are achieved with 
multiple injections made per sample. Utility of this device for application to PPI analysis 
and enzymatic reactions is presented. Specifically, Hsp70-Bag3 interaction and SIRT5 
enzymatic reaction samples were assayed. The results suggest future utility of the device 
and PXCE method for screening of enzyme and PPI modulators. 
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CHAPTER 1: Introduction 
 
Adapted with permission from Ouimet, C. et al. Expert Opin. Drug Discov. 2017, 12, 
213-224. 
Copyright 2017 Taylor & Francis 
 
 
 
Capillary and Microchip Electrophoresis in Drug Discovery 
 
Capillary electrophoresis (CE), and its microfluidic counterpart microchip electrophoresis 
(MCE), have emerged as promising techniques with use in the pharmaceutical industry 
for characterizing biopharmaceuticals1 and drug discovery2,3.  
CE separates molecules based on their differential migration in an electric field. 
In free solution, capillary zone electrophoresis (CZE), the migration of a molecule in an 
applied field is dependent upon its charge and size, enabling separation by either property 
(Figure 1-1A). Modification of the separation media can alter the separation selectivity, 
e.g. capillary gel electrophoresis (CGE) enables separation on size only (Figure 1-1B). 
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Figure 1-1. Schematic of capillary zone electrophoresis (A) and capillary gel 
electrophoresis (B).  In capillary zone electrophoresis analytes migrate based on their 
charge and size. In capillary gel electrophoresis of proteins analytes are sieved an 
entagled polymer matrix based on their size.  
 
Separated molecules are detected by a variety of methods including UV 
absorbance, capacitively coupled contactless conductivity, mass spectrometry (MS), and 
laser-induced fluorescence (LIF). The combination of separation and direct, on-line 
detection enable CE and MCE to be used for many kinds of assays useful for screening. 
Of relevance to drug screening, optical detection is well-suited for detecting enzyme 
activity and affinity interactions. Compared to other drug screening platforms, such as 
fluorescent plate readers, CE offers a number of potential advantages including low 
sample volume requirements (nanoliter or less), rapid separations, and sensitive detection 
of analytes. CE also allows for resolution of confounding components in the assay such 
as interference from optically active test compounds2,4,5, non-specific protein 
aggregation5, and compound precipitation5.  
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A comparison of methods for a kinase screen against fluorescent test compounds 
determined electrophoresis to be preferred over fluorescence polarization, amplified 
luminescent proximity homogenous assay, and enzyme fragment complementation for 
quantifying fluorescent inhibitors.4 The preference for CE was due to the tolerance of the 
CE assay to fluorescent compounds, the assay’s sensitivity, and comparatively low 
substrate and enzyme requirements. In the CE assay the fluorescent compound was 
tolerated because test compound was resolved from the substrate and product. An 
example of similar benefits for a protein-protein interaction assay is illustrated in Figure 
1-2.6 
 
Figure 1-2.  Identification of assay interference in CE based on electropherograms. 
Electropherograms of Hsp70-488 and Bag3 interaction in the presence of (A) complex 
inhibitor epigallocatechin gallate, (B) hematoxylin which caused aggregation identified 
by loss of signal and sharp, unexpected peaks, (C) fluorescent test compound calcein 
causing optical interference.6 Reprinted with permission from reference 6. Copyright 
2013 American Chemical Society. 
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MCE systems have been commercialized for screening. Perhaps the most popular 
system is the LabChip instrument (PerkinElmer), which uses vacuum to pull sample from 
a multiwell plate (MWP) into the microfluidic separation channel with fluorescence 
detection. This system has been used to screen 10 x 384 well plates in 10 h.7 The 
platform has been applied to diverse targets including kinases, phosphatases, proteases, 
phosphodiesterases, epigenetic targets, and nucleic acid binding proteins.2,7–12  
Despite the apparent utility of CE in screening, the technique is not yet widely 
used. One reason for this may be due to the relative complexity of performing CE assays 
where injection, separation and detection are required in comparison to the simpler, more 
common, optical detection methods. Despite these challenges, a variety of strategies for 
improving throughput and sample requirements have emerged. New instruments and 
methods, have the potential to improve throughput and reduce sample consumption of CE 
or MCE for screening.  
Rapid Electrophoretic Separations 
High-throughput screening (HTS) using multiwell plates with optical readouts can 
perform >104 assays per day. The throughput of CE and MCE assays is usually limited 
by the separation time required to resolve the molecules of interest. As commonly 
practiced, CE separation times are a few minutes per sample, however it is possible to 
achieve separations on the second timescale. Throughput may also be improved by 
running separations in parallel or by multiplexing the assay. 
     Strategies for increasing the speed of a separation can be appreciated with a brief 
review of electrophoresis principles. The migration time of an analyte (tmig) in an 
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electrophoresis separation channel with length (L) is dependent upon its electrophoretic 
mobility (µep) under an applied voltage (V):13 
tmig = L2/(V x µep)                        (Eq. 1-1)  
Therefore, to decrease the separation time the applied voltage can be increased or the 
separation length can be decreased. For example, in an enzyme inhibition assay of 
metalloproteinase performed on a commercial CE instrument the separation time was 
decreased from about 250 s to 70 s by simply reversing the polarity of the applied electric 
field and injecting from the ‘outlet’ side of the capillary, near the detection window, 
resulting in a shorter separation length.14 In general however, commercial CE instruments 
have limited accessible separation lengths so that it is difficult to reduce separations to 
shorter than this. Some custom-built CE systems have allowed sub-second 
separations;15,16 however, with one exception17,18, they have not been investigated for 
screening.  
MCE allows for use of shorter separation channel lengths and smaller internal 
diameters than commercial CE systems. Increasing the applied voltage over a given 
separation length can increase the separation speed; however, this approach is limited 
because eventually Joule heating becomes significant enough to create mixing effects that 
destroy the separation. Effective heat dissipation can be achieved by using liquid cooling 
or by lowering separation channel diameters. These strategies enable higher voltages and 
faster separations. MCE with micrometer dimension channels enable separations in 
microseconds to seconds.19 Decreasing the separation channel internal diameter places 
greater demands on the detector to achieve adequate sensitivity. LIF detection is often 
used when low internal diameters are employed because of the inherent sensitivity of 
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fluorescence detection. Despite inherent challenges in coupling electrophoresis to mass 
spectrometry (MS) recent advances in CE-MS interfaces20 may eventually allow 
detection by this label-free, highly selective detector. 
     Another approach to improving throughput is to perform multiple injections rapidly so 
that multiple separations are overlapping in the separation channel at one time. This 
technique, which requires proper spacing of the injections relative to the separation times 
of peaks of interest, increases throughput by eliminating time between runs and taking 
advantage of the time between resolved peaks in a single separation. In one study, the 
total analysis time per sample was reduced by about half with sequential injection.21 This 
approach is most common with CE where the separation time tends to be longer than 
MCE.  
Parallelization and Multiplexing Strategies 
Operating CE or MCE in parallel can also improve the throughput. Challenges in 
developing platforms for running parallel separations include achieving multichannel 
detection, connections to peripheral power supplies, and attaining reliable simultaneous 
separations across parallel separation channels.22 Many of these challenges were met 
when CE was being developed for DNA analysis. The necessity of high throughput 
sequencing led to using arrays of capillaries to run many parallel assays.23 This concept 
has been adapted to drug discovery. A commercial instrumentation with a 96-capillary 
array was successfully applied to enzyme screening with UV absorption detection and 
throughputs of about 30 min per 96 samples without overlapping injections, high fields, 
or short capillaries.24  
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With MCE, parallel separation channel arrays can be made with small footprints 
at no additional fabrication cost. Up to 384 parallel separations have been reported for 
genotyping on a single microfluidic device.25 Such highly parallel chips for screening 
have not yet been reported; however, the LabChip system can be used with 12 channels. 
Higher parallelization may be possible. A 36 channel microfluidic device with gated 
injection has been demonstrated for a model enzyme inhibitor screen with 36 parallel 
assays completed in 30 s.26 Parallelization on chip with fast optically-gated injection has 
been used to perform a high throughput enzyme assay with 4 parallel separations and 30 s 
separation time.27  
Another way to improve throughput is by test compound sample pooling. With 
sample pooling, versus assaying each test compound individually to find hits, a mixture 
of test compounds is assayed. If a hit is identified then each compound in the original test 
compound mixture is assayed individually. The low hit rates typical with screening allow 
far fewer assays to be done if sample pooling is used. Sample pooling for CE screening 
has been demonstrated with 10 test compounds assayed at a time.28  
Multiplexing takes advantage of the separation power of CE to assay multiple 
targets simultaneously.29,30 A four-plexed assay of protein kinases demonstrated 
simultaneous resolution of distinct substrates and products.29 A study of protein-peptide 
interaction targets with src homology 2 (SH2) domains simultaneously assayed three 
proteins (Figure 1-3).30 Such multiplexed assays also provide additional information 
about hit specificity by readily identifying selective and non-selective inhibitors.29,30  
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Figure 1-3. Multiplexed assay of affinity interaction between SH2 domain proteins and 
phosphopeptides. Electropherograms identifying selective (middle) and non-selective 
inhibitors (bottom) of these interactions. Reprinted with permission from reference 30  
copyright  2007, American Chemical Society. 
 
Data Processing 
A challenge of using CE for screening is that large numbers of electropherograms are 
generated which must be analyzed to determine peak areas used for quantification.2 It has 
been shown that batch analysis of electropherograms allows for rapid data processing. 
For example, data processing software (available for download at 
http://kennedygroup.lsa.umich.edu/downloads/) allows for simultaneous analysis of 
hundreds of electropherograms to allow for data analysis on the time-scale of the rapid 
separations. In this strategy hundreds of electropherograms can be aligned based on a 
common peak, corrected for baseline drift, and peaks of interest can be defined.31  
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Sample Introduction 
Although very fast separations are possible by CE and MCE, sample introduction and 
injection are critical parameters to achieving high throughput. Rapid separations in short, 
low volume separation channels require special considerations for sample injection to 
avoid overloading the separation channel with sample. Typical injection volumes are less 
than 1% of separation channel volume, corresponding to 120 pL volume on a 2 cm long x 
20 µm tall x 30 µm wide channel. Rapid, small volume injection techniques include gated 
injection32, optically gated injection27,33, flow-gating interfaces34, and spontaneous 
injection35,36. These methods allow injection of small volumes onto the channel and 
therefore achieve high quality separations in < 10 s; however, commonly used designs 
require that much larger samples (microliters) be loaded into a sample reservoir mounted 
on the chip. This approach therefore requires more sample than necessary for the actual 
electrophoresis separation and is not compatible with rapidly changing from one sample 
to the next. Recent advances in sample introduction methods are showing potential for 
improved throughput of screening.  
Direct Injection from Multi-well Plate 
Most screens are performed from MWP. Transferring samples rapidly and in series from 
the MWP to MCE requires specific fluidic handling components. The LabChip system 
uses “sippers” (capillaries attached to the chip) to dip into the MWP and pull as little as 
10 nL of sample into the chip through a vacuum system. Interestingly, this system does 
not use the high efficiency injection methods described above. Instead, vacuum is used to 
pull samples into the separation channel. Therefore, a limitation of this commercial 
system is that the vacuum-induced flow within the separation channel causes band 
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broadening, limiting the separation efficiencies that can be achieved. Nevertheless, this is 
the only commercial system that allows robust sampling for thousands of assays with 
MCE separations. The screen’s data quality, has been demonstrated by determination of 
Z’-score, where σp and σn are the standard deviations of positive and negative controls 
and µp and µn are the averages of the positive and negative controls (eq. 1-2).  𝑍! =  1−  !(!!!!!)!!! !!                                                 (Eq. 1-2) 
High Z’-scores (>0.8), have been reported using the LabChip platform.2,10  
 When assay reactions are performed in a MWP, the system does not reduce 
sample requirements even though only small volumes are removed from the MWP. The 
use of microfluidics, however, does allow enzymatic reactions to be performed on-chip. 
In on-chip mode, compounds are sipped from MWP and enzyme reagents are added in 
channels so that reactions occur on-chip. In one kinase screen, on-chip reactions reduced 
enzyme consumption 7-fold.7 Due to short on-chip incubation times, however, the on-
chip format requires high concentrations of enzymes and is limited to enzymes with rapid 
turnover (> 30% in 1 min).9  
Injection from Small Sample Volumes 
To reduce sample volumes required for injection, new designs for picoliter injections 
from low sample volumes have been developed.37,38 One platform utilizes a “Slipchip.”39 
This design consists of two plates; one contains sample well and a discontinuous 
separation channel and the other contains a small volume sample well aligned with the 
bottom of the sample well on the other plate. The plates are aligned such that by moving 
one plate relative to the other discrete sub-nanoliter volume samples can be formed in the 
small volume sample well and alignment of this well with the separation channel allows 
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for subsequent injection. The design is also parallelized for analysis from 10 discrete 
samples with 30 parallel separations.38 Changing samples beyond the parallelized 
number, however, currently requires manual manipulations. In another platform, an array 
of nanoliter sample droplets was covered with immiscible oil and picoliter injections 
were achieved spontaneously by surface tension when the capillary tip was removed from 
the sample droplet. An array of 25 samples were injected with RSDs for peak height and 
migration time < 5%.37 Potential exists to scale both of these systems to higher sample 
numbers to achieve higher throughput. 
Injection from Segmented Flow 
Another strategy for rapidly introducing new samples and miniaturizing sample 
requirements is use of droplet microfluidics. In droplet microfluidics, discrete aqueous 
samples are compartmentalized by an immiscible, often fluorinated, carrier fluid. Flow 
focusing and t-junctions can be used to make many droplets from one sample. 40–43  
However, to make a few droplets from many samples, as is necessary in screening, 
different methods are required. In one approach, samples in MWPs are reformatted into 
segmented droplets of nanoliter volume inside tubing by using aspiration to sequentially 
draw up plugs of sample and carrier fluid.17,18,44–47 Microfluidic droplets can then undergo 
further manipulations such as mixing,48–52 merging,53–57 splitting,58–61 addition,46,48,49,62,63 
incubation and extraction,17,64–69 which can enable entire assays to be performed at small 
scale. Indeed, this approach has been used with fluorescence detection to screen 704 
compounds against protein tyrosine phosphatase and high-resolution dose response 
curves were obtained. Sample consumption per data point was reduced 25,000-fold.70 
Droplet microfluidics therefore is emerging as an exciting way to perform screens at 
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much reduced volume and instrument overhead relative to MWP. Use of droplet 
microfluidics offers the potential to take better advantage of the throughput and 
miniaturization possible with MCE. 
One hurdle associated with using droplet microfluidics in CE screening is 
automated injection of droplet samples into the CE separation channel. Injection of 
immiscible, non-conductive, segmenting liquid is not compatible with CE separation and 
has been observed to cause electroosmotic flow instability and plug formation in the 
separation channel leading to shorting and dielectric breakdown of the channel and 
device.64,65,71 Therefore, extraction of aqueous sample from the segmented flow is 
necessary. Passive, active, whole, and partial droplet extraction and injection strategies 
have been reported.17,64–69   
Active extraction uses an electric field to destabilize the fluorinated liquid-
aqueous interface and merge the aqueous sample with a parallel aqueous stream 
providing robust and selective extraction.66 Active extraction coupled to electrophoretic 
separation has yet to be reported. 
Passive extraction is somewhat simpler to integrate, as it does not require external 
input. As seen in Figure 1-4, several passive droplet extraction strategies have been 
coupled to downstream CE separations. Pillar arrays have been applied for complete 
extraction of carrier phase67 and injection of the whole droplet into an electrophoresis 
channel (Figure 1-4A).68 Passive droplet extraction strategies often rely on surface 
modifications to extract the hydrophilic aqueous sample droplet from the hydrophobic 
carrier phase. In one strategy, whole droplets are injected into an electrophoresis channel 
by a multilayer device where a portion of the separation channel is open to the segmented 
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flow channel. The droplet is simultaneously extracted and injected when the aqueous 
sample passes the junction and coalesces with the separation buffer (Figure 1-4B).72 
Interestingly, passive whole droplet extraction and injection assisted by a hydrophobic 
and oleophilic foam was also effectively coupled to capillary gel electrophoretic and free 
solution separations.73 The limitation of whole droplet injection strategies is that large 
injection volumes limit the separation quality.  
In another strategy, a microchip device with a ‘virtual wall’ between hydrophobic 
and hydrophilic channels was fabricated by derivatizing a channel surface to make it 
hydrophobic, allowing for aqueous sample to be discreetly injected (Figure 1-4C).64,65 A 
hybrid polydimethylsiloxane (PDMS)-glass device passively extracted droplets from a 
segmented stream within the hydrophobic PDMS device into a hydrophilic capillary 
connected to a glass microchip for gated injection could be used to introduce small 
volume injections for electrophoretic separation (Figure 1-4D). For screening, droplets 
were catalogued by the presence of a positively charged, rapidly migrating analyte in 
every other droplet which was also used to visualize rinsing between droplets. High 
efficiency, rapid separations were reported with this platform (Figure 1-5).17  
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Figure 1-4. Passive extraction and injection strategies for coupling segmented flow 
sample droplets to electrophoresis separations. (A) Pillar array extraction of oil.68 (B) 
Intersecting segmented flow and separation channel geometry for simultaneous extraction 
and injection.72 (C) Virtual wall used for extraction.64 (D) Hybrid PDMS-glass device 
used for decoupling extraction and injection processes 
(http://pubs.acs.org/doi/full/10.1021/ac502758h).17 Reprinted with permission from 
references listed in sub captions. Copyright Royal Society of Chemistry and American 
Chemical Society. 
 
Several screens have been reported using this technology. Z’-scores of 0.8 were 
reported for protein kinase A and Sirtuin 5 screens using the hybrid PDMS-glass 
extraction approach. Throughputs of 0.2 to 0.5 samples/s have been reported with this 
platform.17,18 To date, these approaches have only been used for up to 1,408 compounds. 
If these rates could be scaled to a large number of samples, then throughput could be 
14,400 samples/8 h day on a single channel system.  
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Figure 1-5. Example of rapid enzyme assay separations achievable by MCE for screen of 
SIRT5 1,280 compounds. Separations of internal standard (R), product (P), and substrate 
(S) were achieved in 250 ms, #1117 is an enzyme inhibitor. Reprinted from reference 18, 
copyright 2016, with permission from Springer. 
 
The throughput of a droplet extraction ‘virtual walls’ device was improved by 
parallelization with three extraction channels on one device and was demonstrated for an 
enzyme assay achieving throughputs of 120 samples in 10 min.69 It seems likely that 
higher throughput could be achieved by parallelizing newer droplet extraction 
techniques.17,18 
Targets  
Enzymes 
As previously mentioned, CE and MCE are amenable to performing enzymatic assays. 
Large screens of over 10,000 compounds have only been achieved using commercial 
microchip systems based on sipping from MWP.3 The advent of droplet microfluidics 
interfaced to MCE may prove to have enough throughput, miniaturization, and robustness 
to provide a step forward for electrophoresis-based screening17,18,64,65,69,71–73; however, 
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this has yet to be proven. The standard approach to enzyme assay by CE is to incubate 
enzyme with substrate and then separate substrate and product. The incubation may be 
performed in a MWP. Reduction in volume may be achieved by mixing on chip or in 
droplet samples as mentioned above. Other strategies, unique to CE, have also been 
demonstrated for analysis of enzyme modulation. These alternate methods include 
electrophoretically mediated microanalysis (EMMA), transverse diffusion of laminar 
flow profiles (TDLFP), and immobilized enzyme reactors (IMERs). Of the techniques, 
only “mix and separate” has been used for large scale screening with other techniques 
being demonstrated on small numbers of compounds (Table 1-1). Examples of screening 
using these techniques are described below. 
Performing enzymatic reactions within the capillary can minimize enzyme 
requirements. In EMMA, reactants are sequentially injected onto the capillary and mixed 
based on their differential electrophoretic mobilities allowing for the enzymatic reaction 
to occur on-line (Figure 1-6A).14,74–79 For enzyme screens, lower IC50 values have been 
determined using EMMA, in comparison to traditional assays. Lower observed inhibition 
has been attributed to the decreased incubation time typical in EMMA.77 EMMA was 
also demonstrated for a two substrate enzyme, glycerol kinase, with four reactant plugs: 
incubation buffer, enzyme and two distinct substrate plugs, mixed in-capillary.79 Small-
scale screening of Chinese herbs and other crude products against enzymatic targets by 
EMMA demonstrated the utility of CE in screening of complex test compound mixtures, 
where potential optical interference is reduced compared to other optical platforms.74–78 
While EMMA requires very little enzyme per assay optimal conditions for the enzymatic 
reaction may be easier to achieve in well plate format. Off-line reactions can be 
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completed in parallel, often with automated liquid handling, by carrying out the 
enzymatic reaction within the capillary, however, on-line incubation limits the 
throughputs achievable. 
 
Table 1-1. Representative CE enzyme assay screens and demonstrations  
Target Assay type Compounds assayed Z-score Reference 
Tyrosine phosphatase Commercial microchip 
platform 
12,648 0.61 7 
Sirt5 Segmented flow 
coupled to MCE 
1,280 0.8 18 
Glycerol kinase EMMA 1 N.D. 79 
Aminopeptidase N EMMA 30a N.D. 77 
Neuraminidase EMMA 24a N.D. 74 
β-N-
acetylhexosaminidase 
TDLFP 1 N.D. 80 
Four human kinases: 
GSK3β, DYRK1A, 
CDK5/p25, 
CDK1/cyclin B 
TDLFP 13 N.D. 81 
Adenosine deaminase 
and xanthine oxidase 
CE-based IMERs 20a 0.82, 
0.74 
82 
L-glutamic 
dehydrogenase 
CE-based IMERs 26a 0.95 83 
Glucose-6-phosphate 
dehydrogenase 
CE-based IMERs 6 N.D. 84 
Alkaline phosphatases CE-based IMERs 3 N.D. 85 
Acetylcholinesterase CE-based IMERs 46a 0.9 86 
Angiotensin-
converting enzyme 
CE-based IMERs 34a N.D. 87 
Not determined (N.D.); electrophoretically mediated microanalysis (EMMA); transverse 
diffusion of laminar flow profiles (TDLFP); Capillary electrophoresis based immobilized 
enzyme reactors (CE-based IMERs). a Includes crude product, natural extract, or Chinese 
traditional herb 
 
In-line assays can also be performed with mixing of small volume pressure-
injected plugs occurring by TDLFP.88 Compared to EMMA, this method does not require 
prior knowledge of differential enzyme and substrate mobilities. The utility of this 
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strategy has been demonstrated first with an assay of a farnesyltransferase target89 and 
was later demonstrated for measuring inhibition with other enzymatic targets.80,81,90 
CE-based IMERs have also been demonstrated as useful for inhibition screening. 
Immobilized enzyme reactors can be fabricated within capillaries for on-line enzyme 
assays, saving enzyme in comparison to bulk assays (Figure 1-6B). CE-based IMERs for 
a wide variety of enzymes have been reported for characterizing enzyme inhibitors.83–
87,91,92 One study demonstrated the possibilities for multiplexing this CE-based IMER 
approach by fabricating an IMER of both immobilized adenosine deaminase and xanthine 
oxidase and was applied to screening of 20 natural extracts with a Z’-scores of 0.82 and 
0.74, respectively. The separation was less than 3 min and the on-line incubation was 2.5 
min. 82  
 
 
Figure 1-6. Schematic of an EMMA strategy for enzyme inhibitor screening where (1) is 
depiction of sequential injection of plugs (2) polarity switching for mixing between plugs 
(3) separation of enzyme, substrate and product (A).14 Schematic of CE-IMER for 
GAPDH.84 Reprinted with permission from reference 14 and 84. Copyright 2011 American 
Chemical Society and Elsevier. 
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Affinity Interactions 
Noncovalent binding between two molecules can induce a mobility shift allowing 
electrophoretic separation. Many different assay schemes have been demonstrated for 
detecting and quantifying affinity interactions by MCE.1,93,94 Noncovalent interactions 
assayed by CE include protein-nucleic acid1,12,93, protein-peptide28,30,95, protein-protein 
6,96–99, nucleic acid-small molecule100,101, and protein-small molecule interactions102–107. 
Of these, a “mix and separate” approach, sometimes called affinity probe CE 106, is 
perhaps the most amenable for high throughput screening. If the kinetics of dissociation 
are slow in comparison to the separation time, distinct free protein and protein complex 
peaks are observed enabling quantification of the bound to free ratio. Rapid separations 
are therefore preferable for both throughput and maintaining the complex of interest. A 
limited number of affinity interaction-based screens have been reported (Table 1-2). 
Table 1-2. Representative CE affinity interaction screens.  
Target Assay type Compounds assayed 
Separation 
Time a Z-score Reference 
Tat-TAR Commercial 
microchip 
platform 
1 ~3 min N.D. 12 
Hsp70-Bag3 APCE 3443 3 min 0.78 6 
Bcl-XL-Bid CE-FA 105b 10 min 0.86 28 
Hsp90α CEfrag 609 10 min 0.6 108 
Thrombin PF-ACE 21 10 min N.D. 107 
Not determined (N.D.); affinity probe capillary electrophoresis (APCE); capillary 
electrophoresis-frontal analysis (CE-FA); fragment screening using capillary 
electrophoresis (CE-frag), partial filling affinity capillary electrophoresis (PF-ACE) 
a. Does not include capillary regeneration time between samples. 
b. Includes crude product, natural extract or Chinese traditional herb. 
 
Affinity probe CE (APCE) on a microchip has been used to study protein-nucleic 
acid interactions.12,94,95 In one example, the protein-nucleic acid interaction between 
human immunodeficiency virus 1 transactivator of transcription (Tat) and transactivation-
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responsive RNA (TAR) was studied using a commercial microchip platform. Inhibition 
of the Tat-TAR complex was demonstrated using a known inhibitor and dose dependent 
inhibition of the Tat-TAR complex peak was observed, suggesting the potential 
application of this platform to screening of affinity complexes.12  
Protein-protein interactions (PPIs) represent a large class of targets that were, 
until recently, considered intractable. It can be difficult to predict small molecule 
modulators of these interactions as they often occur with high affinities over large, flat 
surfaces. Recent success in targeting these interactions has led to an increased interest in 
screening against them.109,110 CE has potential as a useful screening technique because of 
the capability of high efficiency separation of large molecules. 
CE has been used in studies of amyloid aggregation111–113, protein-peptide 
interactions28,30,96, and full length PPIs 6,97–99,113. Most of these studies have been proof of 
concept assays; however, one assay did investigate a screen of 3,443 compound library 
against a target PPI. In this study, a fluorescently labeled heat shock protein 70 (Hsp70) 
in complex with its co-chaperone Bcl2-associated athanogene 3 (Bag3) was separated by 
CE. The resulting screen yielded a 1.4% hit rate. A 3.4% hit rate was achieved for the 
same screen using flow cytometry protein interaction assay (FCPIA). The lower hit rate 
in the CE assay was attributed to the identification of detection interfering compounds 
that may be false positives in other assays, such as fluorescent test compounds in the 
screening library and unexpected aggregation of proteins which could be readily 
identified by visual inspection of the electropherograms (Figure 1-2). Comparable Z’-
scores of 0.78 for CE and 0.86 for FCPIA were found for these parallel screening 
platforms. The CE assay was not optimized for throughput however, as it used a 
	 21	
commercial, single-channel CE system, and could only perform 220 assays/day. At this 
throughput CE is potentially more useful as a secondary screening platform.6 In principle, 
such assays could be converted to parallel CE or MCE formats for higher throughput. 
Although the APCE approach is most amenable to screening, CE-frontal analysis 
(CE-FA) has been used to measure affinity interactions. In CE-FA, relatively large 
volumes of equilibrated binding partner mixtures are injected. The large injection volume 
allows for maintenance of interaction during the separation because the free and complex 
zones are largely overlapping during the separation. The interaction between apoptosis 
regulatory, B-cell lymphoma 2 (Bcl-2) family proteins Bcl-XL and BH3-interaction 
domain (Bid) was studied using a fluorophore-labeled peptide form of Bid. 
Quantification was achieved based on the plateau height of the free ligand. A high Z’-
factor of 0.86 was determined for this method and a screen using sample pooling of 60 
compounds with 10 compounds per sample was demonstrated with 10 min/sample 
separation times.28 
Assays for small molecule ligand interactions with proteins, peptides, and nucleic 
acids have been demonstrated by monitoring the mobility shift of the large molecule in 
the presence of small molecule.102–104 Small molecule mobility shift assays can be 
challenging, with some binding events only inducing small changes in large molecule 
mobility.103 Still, fragment-based screening has been demonstrated by affinity CE 
(CEfrag).105 Successful fragment library screening relies on the ability to detect small 
amounts of inhibition as well as assay compatibility with high concentrations of test 
compound. A screen of heat shock protein 90α (Hsp90α) by a mobility shift assay with 
competitive inhibition was successful applied to a fragment library screen.  In this 
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method a small molecule affinity probe that is known to bind to the target molecule is 
used as an indicator of binding. When the affinity probe small molecule is unbound, it 
has a different migration time then when it is bound to its target. When another molecule 
competes with the affinity probe for target binding a mobility shift is observed and a hit is 
identified. For Hsp90α, using radicicol, a molecule known to interact with Hsp90α as the 
affinity probe, weaker affinity hits (>500 µM IC50 values) were identified using CE with 
UV detection versus with a fluorescence polarization assay in a screen of 609 
compounds. The throughput of this screen was 100 samples/instrument/day using a 4-
capillary instrument and a Z factor of 0.6 was determined.108 Similarly, affinity CE was 
demonstrated for fragment based drug discovery targeting thrombin. In this method, the 
capillary was partially filled with a plug of target molecule, a plug of fragment was 
injected and a hit was identified based on a shift in migration time of the fragment in the 
presence of target.107 
A number of obstacles still exist for developing CE methods for screening affinity 
interactions; the protein complex may dissociate during the separation, many interactions 
induce only a small shift in mobility, and proteins tend to adsorb to the wall of the fused 
silica capillary which, depending on severity can cause shifts in migration time as well as 
loss of signal. Capillary coatings are useful for reducing protein adsorption. A number of 
recent studies have successfully characterized capillary coatings several of which are 
compatible with physiological pH and avoid adsorption that was observed on bare-fused 
silica capillary.114–117 Recently, a permanent coating for protein separation was observed 
to have an electroosmotic flow RSD of only 0.5% over one month.118 Unfortunately, a 
coating that prevents adsorption of one protein may not be as effective at preventing 
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adsorption of a different protein116,118 and replacing dynamic coatings between 
separations decreases throughput. The small mobility shift and protein adsorption issues 
must be overcome using conditions that maintain the non-covalent target interactions.  
Target Protein-Protein Interactions 
The CE methods should have wide use for different proteins. In this work, we have 
targeted chaperone proteins and transcription regulation machinery to test these methods.  
 
Chaperone Proteins 
 
Chaperone proteins are critical for maintaining proteostasis. Various heat shock proteins 
perform chaperone functions including binding, unfolding, disaggregation, and 
stabilization of target proteins.119 Two such proteins, Hsp70 and Hsp90 perform 
chaperone functions regulated by a large number of co-chaperone binding partners. 
Hsp70 and Hsp90 have been implicated in cancer and neurodegenerative diseases making 
them potential therapeutic targets.119–121  
Hsp70 function is regulated by interactions with Hsp40, nucleotide exchange 
factors119 including Bcl-2 associated athanogene (Bag), and the ubiquitin ligase CHIP122. 
Interestingly, knockdown of Bag3 has been observed to decrease survival in cancer cell 
lines.123 Benzothiazole rhodacyanine derivatives have been identified as small molecule 
inhibitors of Hsp70-Bag3 interaction.124 These compounds bind to an allosteric site 
within the nucleotide-binding domain stabilizing the ADP state and preventing 
interaction of Hsp70 with Bag3.125 
Hsp90 is notable among chaperone proteins for being a functional homodimer. 
Hsp90 undergoes dramatic nucleotide dependent structural rearrangements. For example, 
in the apo-nucleotide state the c-terminal domains of Hsp90 monomers interact, in the 
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ATP-bound state both the n-terminal and the c-terminal domains interact.126 Hsp90 
substrate binding is regulated by interactions with a large number of co-chaperones 
including p50 and FKBP52.119,126 Heat shock organizing protein (HOP) serves as the link 
between Hsp70 and Hsp90 chaperone systems and is thought to be responsible for 
transferring client proteins from Hsp70 to Hsp90.126 While these chaperone proteins are 
interesting biological targets with roles in cancer and neurodegeneration they also present 
an analytical challenge owing to the diversity of protein interaction affinities and binding 
interfaces.  
 
KIX Domain of CREB-Binding Protein (CBP) 
 
Transcription is regulated by protein-DNA and protein-protein interactions. One example 
is CREB-binding protein (CBP) which is a co-activator of transcription that interacts both 
with transcription factors and transcription machinery. The kinase inducible domain 
interacting domain (KIX) of CBP has been found to interact with a large number of 
transcription factors including c-myb, E2A, p53, and MLL.127,128 CBP and transcription 
factors are thought to play a key role in tumors and neurological disorders.129,130 Due to 
the role of the KIX domain in transcriptional activation targeting of its interactions is 
seen as of potential interest.127,131 
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Dissertation Overview 
This work aims to simplify method development and increase throughput for 
analysis of protein-protein interactions by capillary and microchip electrophoresis.  
Difficulties in maintaining interactions during the separation are addressed by covalently 
cross-linking interacting proteins prior to electrophoresis. Improvements in capillary and 
microchip gel electrophoresis throughputs are also explored.  
In Chapter 2, a covalent cross-linking approach is demonstrated to simplify 
method development for capillary electrophoresis of several protein-protein interactions 
with nanomolar dissociation constant (Kd) values. The strategy involves a 10 min 
formaldehyde cross-linking reaction and affords separation throughput of about 15 
min/sample using capillary gel electrophoresis. The strategy was demonstrated for 
determination of dissociation constants and IC50 values for known interactions and 
inhibitors, respectively. 
In Chapter 3, limitations of the method presented in Chapter 2 were addressed. 
The throughput of the above method was increased to about 1 min/sample, the cross-
linking reaction time was decreased to 10 s, and the method was further applied to more 
diverse interactions with nanomolar to micromolar Kd values.  
Chapter 4 presents the development of a microfluidic approach for further 
increasing the throughput of the protein cross-linking electrophoresis strategy by 
integrating segmented flow for sample introduction onto microchip gel electrophoresis 
device. Immiscible segmenting carrier phase was drained based on density using a novel 
device design. The device was then demonstrated for for enzyme and protein-protein 
interaction assays.  
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Chapter 5 discusses future directions for addressing the limitations of this work. 
Strategies for further improvements to separation and injection throughput are presented. 
Further, potential for label free and online protein cross-linking capillary electrophoresis 
assays are also discussed.   
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Chapter 2: Protein Cross-linking Capillary Electrophoresis for Protein-Protein 
Interaction Analysis 
 
Adapted with permission from Ouimet, C. et al. Anal. Chem.  2016. 88. 8272-8278. 
Copyright 2016 American Chemical Society. 
 
 
Introduction 
 Protein-protein interactions (PPIs) control many cellular functions. As a result, it 
is important to be able to quantify these interactions. It is also of interest to identify small 
molecule modulators of PPI for use as probes for chemical biology and as possible drugs. 
The diversity and transient nature of PPI can make them challenging to study. Several 
techniques have been developed for PPI analysis including flow cytometry protein 
interaction assays (FCPIA), isothermal titration calorimetry (ITC), fluorescence 
polarization, in silico methods, nuclear magnetic resonance (NMR), surface plasmon 
resonance (SPR), fluorescence resonance energy transfer (FRET) and AlphaLisa. Each of 
these techniques has strengths and weaknesses and can be chosen for different 
applications. For example, for screening chemical libraries to identify potential 
modulators of PPI, many of these techniques are impractical because of quantification, 
throughput, or sample consumption considerations. In this work we explore the use of 
protein cross-linking CE (PXCE) for detecting and quantifying PPIs. 
 PXCE is a variant of affinity probe capillary electrophoresis (APCE). In APCE, 
an equilibrated mixture of binding partners is electrophoresed to allow for detection of 
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non-covalent interactions.93,106,132 APCE has been used to investigate many biomolecular 
interactions such as protein-protein6,97,98,113, antibody-antigen133–138, protein-
DNA114,135,139–141, protein-peptide30,135 and protein-aptamer115,142,143. Typically, one 
binding partner is fluorescently labeled enabling sensitive detection by laser induced 
fluorescence (LIF). APCE offers advantages of low sample volume requirements, high 
throughput, and highly sensitive direct detection of free protein and protein complex. 
These advantages make APCE a potentially powerful approach for characterizing PPI 
and other non-covalent biomolecular interactions. The utility of this approach for 
screening for modulators of PPI was demonstrated in a study of the heat shock protein 70 
(Hsp70) and Bcl-2 associated athanogene 3 (Bag3) interaction.6 The CE assay was found 
to be more selective than an FCPIA screen based on the minimal perturbation of the 
proteins for the assay and the ability to discern fluorescent test compounds and protein 
aggregation in the CE data. These features eliminated many false positives.  
 Although possessing many advantages for detecting, quantifying, and screening 
PPIs, APCE is limited by the need to have separation conditions that both maintain 
protein interactions over the course of the separation and also prevent protein adsorption 
to the capillary. Strategies to minimize protein-wall interactions include capillary 
derivatization,6,114,115,140 extreme pH,144,145 surfactant additives146 and high ionic strength 
buffers.147,148 Techniques to minimize protein adsorption to the capillary are often not 
compatible with maintaining non-covalent protein interactions or require optimization for 
each protein binding partner of interest. As a result, it is often difficult and slow to 
develop CE methods for PPI, greatly limiting the use of this technique. 
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In this work, we examine protein cross-linking prior to CE separation for 
detecting and quantifying PPI. This process allows complexes to be formed under 
binding conditions and then separated under non-native or denaturing conditions, 
facilitating method development. Previously protein cross-linking prior to CE analysis 
has been used to check the success of cross-linking for different carbodiimide cross-
linkers.149 In another study, cross-linking prior to CE was used to screen for dimer 
formation in therapeutic antibody samples.99 Good agreement was found for results by 
CE and size exclusion chromatography without cross-linking suggesting the potential for 
more in-depth, quantitative assays.  
Here, the utility of PXCE was investigated for determining Kd of three protein-
protein complexes: the antibody-antigen complex of lysozyme-anti-lysozyme, Hsp70-
Bag3 heterodimer and heat shock protein 90 (Hsp90) homodimer. PXCE was also 
applied to quantify inhibition of PPIs with Hsp70-Bag3 binding site mutants and small 
molecule inhibitors. Formaldehyde was chosen as the cross-linking reagent because of its 
short reaction time and reactivity toward many amino acid residues.150 The complexes 
chosen present different challenges and opportunities. Lysozyme and Bag3 have been 
identified as a difficult proteins to analyze using CE because they strongly adsorb to the 
inner wall of fused silica capillaries resulting in missing peaks6 or poor peak shape144. 
Heat shock proteins including Hsp70 and Hsp90 and their co-chaperone interactions have 
been identified as potential drug targets.121,151  
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Experimental 
Chemicals and Materials 
Unless otherwise specified reagents were purchased from Sigma Aldrich (St. Louis, MO). 
Lysozyme, Alexa Fluor 488 5-SDP ester and Alexa Fluorophore 488 NHS ester were 
purchased from ThermoFisher Scientific (Waltham, MA). All separation and assay 
buffers were made using water deionized to 18 MΩ using a Series 1090 E-pure system 
(Barnstead Thermolyne Cooperation; Dubuque, IA).  
Protein Purification and Labeling 
Hsp70 and Bag3 were expressed and purified as previously reported.6,152–154 Hsp90 was 
subcloned into pET28 vector to incorporate N-terminal 6x-His tag. Plasmid was 
transformed into BL21(DE3) One Shot start cells (Invitrogen; Carlsbad, CA) and purified 
on a Nickel-NTA column followed by size exclusion chromatography (SEC) on a HiLoad 
16/600 Superdex 200 PG column (GE Healthcare; Piscataway, NJ). The concentrated 
SEC fraction was labeled with Alexa Fluor 488 NHS Ester according to manufacturer 
instructions and dialyzed into phosphate buffered saline, pH 7.4. Hsp70 and Hsp90 were 
labeled with Alexa Fluor 488 5-SDP ester. Lysozyme was incubated with a final 
concentration of 100 µg/mL fluorescein isothiocyanate (FITC) for 1 h at room 
temperature and dialyzed into phosphate buffer, pH 7.5. 
Protein Cross-linking Capillary Electrophoresis 
Protein samples were allowed to equilibrate in 25 mM HEPES, 10 mM KCl, 5 mM 
MgCl2 and 0.3% (w/v) Tween-20, pH 7.5. Small molecules were dissolved in DMSO and 
spiked into protein samples to a final concentration of 1% DMSO for all dose response 
samples, including positive and negative controls. Samples were incubated for at least 15 
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min prior to cross-linking. Proteins were cross-linked at room temperature by addition of 
formaldehyde, prepared from paraformaldehyde, to a final concentration of 1% (w/v) 
formaldehyde for 10 min unless otherwise stated. Cross-linking reactions were quenched 
by adding Tris to a total concentration of 20 mM and, for gel electrophoretic analysis, 
0.2% (w/v) SDS. 
All CE experiments were carried out using a Beckman Coulter P/ACE MDQ 
(Fullerton, CA) equipped with a Sapphire laser (Coherent; Santa Clara, CA) with 488/520 
nm λexcitation/λemission filters for LIF. Data were collected by 32 Karat software and 
analyzed using Cutter 7.0.31 Binding data and IC50 curves were fit by non-linear 
regression using Prism 6.0 (GraphPad Software; San Diego, CA). All separations were 
carried out in 360 µm outer diameter fused silica capillary with 50 µm internal diameter 
for free solution electrophoresis and 40 µm internal diameter for gel electrophoresis 
separations (Polymicro Technologies; Phoenix, AZ). The total capillary length was 30 cm 
with 10 cm to detection window. Free solution electrophoresis of FITC labeled lysozyme 
(FITC-lysozyme) and anti-lysozyme was carried out in 10 mM sodium tetraborate, pH 
10, electrophoresis buffer. Samples were injected by pressure at 0.5 psi for 5 s and 
electrophoresed with an applied field of 500 V/cm.  
For gel electrophoresis separations of Hsp90 Alexa Fluor 488 (Hsp90-488), 
Hsp70 Alexa Fluor 488 (Hsp70-488) and Bag3 the capillary was pre-conditioned with 1 
M NaOH, H2O and UltraTrol LN (Target Discovery; Palo Alto, CA) for 3 min each 
followed by introduction of dextran sieving matrix (180 mM boric acid, 200 mM Tris, 1 
mM EDTA, 13.8 mM SDS, 7% w/v 1.5-2.8 MDa dextran, 10% w/v glycerol) at 40 psi 
for 10 min. Samples were injected electrokinetically at 15 kV for 1 min and 
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electrophoresed with applied fields of 567 V/cm. Capillaries were regenerated by 
flushing with H2O followed by preconditioning when a shift in migration time was 
observed, usually after 1 hour of use.  
Isothermal Titration Calorimetry 
Titrations were performed on a NanoITC 2G (TA Instruments; New Castle, DE). Data 
were collected using Nano ITCRun software and a dissociation constant value was 
calculated using NanoAnalyze software (TA instruments). The syringe contained 6 µM 
FITC-lysozyme for titration into 0.2 µM anti-lysozyme in the cell.  
Results and Discussion 
CE-LIF of Interacting Proteins 
Hsp70, Hsp90 and lysozyme were fluorescently labeled to allow for sensitive LIF 
detection. We initially attempted separation of the free proteins and complexes with the 
binding partners by CE-LIF without cross-linking (Figure 2-1 and 2-2). For all three 
examples of interacting pairs, detection of complexes was difficult without cross-linking.  
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Figure 2-1. Free solution electrophoresis of chaperone complexes Hsp70-488-Bag3 (A) 
and Hsp90-488 homodimer (B). The electrophoresis buffer was 10 mM, pH 10 borate. 
 
The Hsp70-Bag3 interaction has previously been identified as a difficult PPI for 
CE method development due to adsorption of Bag3 to fused silica capillary around pH 7.6 
We found adsorption of Bag3 to be a persistent problem, even at pH 10, so that no 
discernible complex peaks were observed in samples containing Hsp70-488 and Bag3 
when using free solution CE (Figure 2-1A). Bag3 adsorption is likely a result of it being 
intrinsically disordered which is common with PPI targets.155 (Previous study used 
capillaries covalently modified with a perfluorinated alkylating agent to prevent 
adsorption of Bag3.) With free solution electrophoresis of Hsp90-488 at pH 10, protein 
adsorption was not observed; however, monomeric Hsp90-488 was not readily resolved 
from the dimeric form suggesting very similar electrophoretic mobilities of dimer and 
monomer (Figure 2-1B). A free solution CE separation of FITC-lysozyme-anti-lysozyme 
at pH 10, in the absence of cross-linking, results in multiple unresolved peaks possibly 
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due to dissociation and association occurring on the time scale of the separation (Figure 
2-2C).   
 
Figure 2-2. Electropherograms with (red trace) or without (black trace) cross-linking of 
protein complexes of (A) Hsp70-488-Bag3, (B) Hsp90-488 dimer, and (C) FITC-
lysozyme-anti-lysozyme. Separation was performed with (A,B) dextran gel and (C) free 
solution with pH 10, 10 mM borate electrophoresis buffer. Cross-linking was with 1% 
formaldehyde for 10 min in HEPES buffer. Table 2-1 provides resolution between free 
and complex peaks for the cross-linked electropherograms. 
 
A potentially better approach to separation of protein complexes is capillary gel 
electrophoresis (CGE) in presence of SDS, e.g. using an entangled polymer solution as a 
sieving media (SDS-CGE).156 SDS-CGE facilitates predictable protein separation based 
on size; however, the denaturing conditions disrupt PPI so that Hsp70-Bag3 and Hsp90 
dimer protein complexes could not be detected. Indeed, only free protein was detected for 
mixtures of these interacting proteins separated by SDS-CGE (Figure 2-2). A similar 
effect was observed for FITC-lysozyme-anti-lysozyme (Figure 2-3). The results with the 
non-cross-linked complexes illustrate the different challenges of developing APCE 
assays for PPI. 
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Figure 2-3. Capillary gel electrophoresis separation of FITC-lysozyme immunocomplex. 
 
Cross-linking Conditions.  
To overcome the challenges associated with detection of non-covalent interactions by 
CE, interacting proteins were cross-linked prior to electrophoresis. Covalent cross-linking 
of interacting proteins with formaldehyde allowed for the direct detection of free protein 
and protein complex using the denaturing gel separation for the chaperone complexes 
(Figure 2-2A,B) and a high pH electrophoresis buffer for FITC-lysozyme-anti-lysozyme 
(Figure 2-2C), with acceptable resolution (Table 2-1). This result shows that cross-
linking facilitates detection of interacting proteins by free solution CE or SDS-CGE 
separations. 
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Table 2-1. Resolution of free proteins from protein complexes. 
Complex Resolution 
Hsp70-Bag3 1.0 
Hsp90 homodimer 2.0 
Lysozyme-anti-lysozyme 1.1 
 
The effect of cross-linking conditions, such as reaction time and formaldehyde 
concentration, on amount of complex detected was determined for the Hsp70-Bag3, 
lysozyme-anti-lysozyme and Hsp90 homodimer (Figure 2-4). In this study, the amount 
of complex formed was quantified as the complex peak area as a percentage of total peak 
area to account for any artifacts from instability of the laser source or injection 
variability. It has previously been reported that different PPIs require different cross-
linking conditions;157 however, most formaldehyde cross-linking assays, such as 
chromatin immunoprecipitation and mass spectrometry, utilize between 10 and 20 min of 
cross-linking with 0.05-1% formaldehyde.158,159 A range of reaction conditions can be 
easily tested with CE separation to determine conditions that favor high yields for a 
particular PPI. Cross-linker concentration and reaction time are considered largely 
complimentary with a general increase in yield expected for an increase in either.99,150,157  
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Figure 2-4. Dependence of (A) 25 nM Hsp70-488 and 100 nM Bag3 (B) 50 nM Hsp90-
488 and (C) 10 nM FITC-lysozyme and 20 nM antibody on dimer complex detected on 
concentration of formaldehyde and cross-linking reaction time.   
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An increase in Hsp70-Bag3 complex peak area was detected with increasing 
formaldehyde concentration or time up to 2.5% formaldehyde or 30 min of cross-linking, 
respectively, while FITC-lysozyme-anti-lysozyme appeared relatively insensitive to the 
times assayed with 0.5 to 1% formaldehyde. The amount of Hsp90 dimer complex 
observed was fairly stable for all reaction times and concentrations assayed. Interestingly, 
the amount of complex detected decreased if the cross-linking reaction was allowed to 
proceed for 60 min. A trend toward decreasing apparent yields of complex at high cross-
linking times has been previously reported by mass spectrometry.157 This effect may be 
due to the formation of higher molecular weight aggregates, which are not injected onto 
the gel columns. For all complexes, the amount of complex observed was within a range 
of 13% for 10 min of cross-linking reaction with 0.5-2.5% formaldehyde. These results 
show that, at least for these proteins, finding conditions for maximal complex formation 
is straightforward and the results will be stable over a wide range of conditions.  
To favor high yields of cross-linking and short reaction times, an intermediate 
cross-linking reaction condition of 10 min and 1% formaldehyde was chosen for further 
assay testing. To minimize artifacts when cross-linking high concentrations of 
protein99,150, interacting proteins were investigated in the nanomolar to low micromolar 
concentration range. This concentration range is also more useful for determining 
quantitative binding data for many proteins. 
PXCE fundamentally requires cross-linkable residues in the protein-protein 
interaction site. Although formaldehyde is efficient and reacts with many residues, other 
PPIs may benefit from different cross-linkers with longer spacer arms or more controlled 
reactivity.160 Information about the PPI site may facilitate the choice of cross-linker. 
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Determination of Binding Affinities 
To determine if PXCE allows for quantitative affinity information to be obtained, 
saturation binding assays were performed and the data fit by non-linear regression to 
determine Kd (Figure 2-5).  
 
Figure 2-5. Determination of dissociation constant (Kd) for (A,B) Hsp70-488-Bag3 (C,D) 
Hsp90-488 dimer and (E,F) FITC-lysozyme-antibody. Electropherograms for (A) 25 nM 
Hsp70-488 at increasing concentrations of Bag3, (C) 1, 20 and 100 nM Hsp90-488 and 
(E) 10 nM FITC-lysozyme with increasing concentrations of monoclonal antibody 
(mAb). Non-linear regression determined a Kd of (B) 25 ± 5 nM for Hsp70-488-Bag3, 
(D) 2.6 ± 0.3 nM for Hsp90-488 and (F) 24  ± 3 nM FITC-lysozyme-antibody. Error bars 
are standard deviation (n = 3). 
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Hsp70-488 and Bag3 were found to interact with a Kd = 25 ± 5 nM by PXCE. 
Previously the Kd for this pair has been reported as 23 ± 8 nM with Hsp70-488 by APCE 
and 15 ± 2 nM with unlabeled Hsp70 by ITC, both without cross-linking.6 Similar Kd 
values were found using 5, 10 and 20 min cross-linking reactions (Figure 2-6, Table 2-
2).  
Figure 2-6. Saturation binding assays for Hsp70-488-Bag3 at different 1% formaldehyde 
reaction times. All samples contain 25 nM Hsp70-488, error bars are standard deviation 
(n = 3). 
 
Table 2-2 Dependence of measured Kd of Hsp70-488-Bag3 interaction on cross-linking 
reaction time using 1% formaldehyde. 
 
Cross-linking reaction time (min) Kd, Hsp70-Bag3 (nM) 
5 25 ± 8 
10 25 ± 5 
20 29 ±6 
 
Hsp90-488 was found to form a homodimer with Kd = 2.6 ± 0.3 nM by PXCE. 
The Kd of Hsp90 homodimerization was previously reported to be 60 ± 12 nM by size 
exclusion chromatography. In this technique, association and dissociation occur over the 
timescale of the separation, and the elution time is used as an indicator of the degree of 
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dimerization.161 A dissociation constant for the Hsp90 homodimer could not be obtained 
by ITC possibly due to the limitations with quantifying homodimers with nanomolar Kd 
values by ITC. More recently, a Kd value of 1.29 nM was reported for Hsp90 
dimerization.162  The Kd value determined for FITC-lysozyme-anti-lysozyme by PXCE 
was determined to be 24 ± 3 nM by PXCE and 17 ± 2 nM by ITC with 1:2 antibody to 
FITC-lysozyme stoichiometry (Figure 2-7). Thus, for Hsp70-Bag3 and FITC-lysozyme-
anti-lysozyme PXCE gave Kd values similar to ITC, which used non-cross-linked 
proteins. The largest discrepancy was for Hsp90 dimerization and may be due to 
differences in the conditions used for the interacting proteins.  
 
 
 
 
 
 
 
 
 
 
 
Figure 2-7. Calorimetric isothermal-titration measurement of FITC-lysozyme interaction 
with anti-lysozyme.  
 
 
To determine if PXCE is useful for ranking PPI affinities, a competitive binding 
experiment was carried out with Hsp70 proteins containing mutations in key residues 
within the Bag3 interaction site that have previously been reported to inhibit Hsp70-Bag1 
interactions (Figure 2-8A).163 Unlabeled wild type and mutant Hsp70 were titrated into a 
fixed concentration of Bag3 and Hsp70-488 to determine the affinity of unlabeled Hsp70 
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for Bag3. In these experiments, adding unlabeled Hsp70 variants decreased the complex 
peak area for Hsp70-488 allowing quantification. A higher concentration of mutant 
Hsp70 than wild type Hsp70 was required to compete with the Hsp70-488 for Bag3 
binding (Figure 2-8A). The data were normalized to positive (no Bag3 added) and 
negative controls (no unlabeled Hsp70) to quantify the percent inhibition. The inhibitory 
constant (Ki) was determined to be 9 ± 2 nM for unlabeled wild type Hsp70, 160 ± 60 nM 
for Hsp70 E,D 283, 292 A,A and 400 ± 200 nM for Hsp70 R,R 258,262 A,A by PXCE. 
The inhibitory constant for the unlabeled wild type Hsp70 is lower than the Kd found for 
the Hsp70-488, in agreement with the Kd = 15 ± 2 nM previously reported by ITC for the 
unlabeled Hsp70-Bag3.6 For comparison, inhibitory constants were determined by 
FCPIA with similar Ki = 15 ± 8 nM determined for the wild type and 190 ± 30 for the 
E,D 283, 292 A,A mutant and 900 ± 300 for the R,R 258, 262 A,A mutant. In FCPIA one 
binding partner is immobilized on a bead while the other is fluorescently labeled, the 
binding partners are incubated and a flow cytometer is used to determine bead associated 
fluorescence. There are multiple differences in the PXCE and FCPIA assay formats 
including different fluorescent labels and the requirement of FCPIA to immobilize one of 
the binding partners on a bead, which could interfere with the PPI affinity. Despite these 
assay differences, the rank order of FCPIA and PXCE for the wild type and mutant 
interactions is the same (Figure 2-8B). Kis were also in good agreement with the largest 
discrepancy being a factor of two higher Ki for the Hsp70 R,R 258 262 A,A mutant by 
FCPIA.   
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Figure 2-8. Determination of inhibition constant (Ki) of Hsp70 proteins by (A) PXCE. 
Increasing concentration of unlabeled Hsp70 (Wild-Type), Hsp70 E,D 283, 292 A,A or 
Hsp70 R,R 258, 262, A,A with 25 nM Hsp70-488 and 50 nM Bag3. Error bars are 
standard deviation (n = 3). (B) Comparison of Ki values obtained by PXCE and FCPIA.   
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Quantification of PPI Small Molecule Inhibitors 
We next examined the possibility of using PXCE to determine the inhibition of PPI by 
small molecules. We tested 3 compounds that are known to inhibit the Hsp70-Bag3 
interaction: JG-311, JG-98, and JG-231.164–166 As shown in Figure 2-9, PXCE allowed 
detection of protein complex inhibition for these compounds. IC50 values were 
determined to be 1.3 ± 0.1 µM, 800 ± 200 nM and 400 ± 200 nM for JG-231, JG-98 and 
JG-311, respectively. The small molecules were all found to have similar IC50 values 
with similar associated errors by dose response using both PXCE and FCPIA assays 
(Figure 2-10).  
 
Figure 2-9. Quantification of small molecule inhibitors by PXCE. Electropherograms of 
(A) Hsp70-Bag3 negative control and Hsp70-488-Bag3 in the presence of fluorescent 
inhibitor. (B) Dose response curves for JG-231, JG-98 and JG-311. Log(IC50) values were 
determined to be -5.9 ± 0.1 for JG-231, -6.1 ± 0.3 for JG-98 and -6.3 ± 0.2 for JG-311. 
JG-258 was used as negative control and 1 µM unlabeled Hsp70 was used as a positive 
control. Error bars are range of two trials.  (C) Comparison of IC50 values obtained by 
PXCE and FCPIA. 
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Figure 2-10. FCPIA data of small molecule Hsp70-Bag3 inhibitors JG-98, JG-231 and 
JG-311. Error bars are range of two trials.  
 
These experiments also illustrate a potential advantage of PXCE for screening of new 
modulators of PPI. All of the tested molecules are fluorescent. Fluorescent drug 
molecules can interfere with detection of PPI modulators in many fluorescence assays. 
PXCE has the advantage of identifying potentially interfering fluorescent small 
molecules on the basis of extra peaks and allows for separation of the fluorescent small 
molecules from free protein and protein complex. Using a gel electrophoresis separation, 
small molecule compounds migrated much more rapidly than the high molecular weight 
proteins (Figure 2-9A) allowing for quantification of inhibitor potency despite 
fluorescence of small molecule. The denaturing gel conditions likely also promoted 
dissociation of the small molecule from the protein allowing for separation without 
quantitative interference. The limiting factor is that strongly fluorescent molecules can 
dominate the electropherograms at high concentrations. In this case, the assay allowed for 
quantification of free and bound protein peaks for up to 50 µM JG-311, JG-98 and JG-
231. 
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Implications and Limitations 
This work demonstrates the utility of formaldehyde cross-linking for nanomolar 
interaction affinities. It has been reported that equilibrium shifts are minimized and 
quantitative information is attainable with cross-linking for high affinity complexes when 
free proteins that react with the cross-linker do not then bind and cross-link to other 
proteins and when high efficiency cross-linkers are used in large excess.167 Cross-linking 
of rapidly dissociating PPIs may be challenging as it has been reported that such PPIs are 
not readily captured with formaldehyde cross-linking.168 Faster reacting reagents may be 
preferable for such cases to eliminate the chance of complex dissociation or additional 
complex formation. Despite these caveats, the data presented suggest that formaldehyde 
with PXCE will be broadly useful for different types of proteins and for different 
applications such as affinity determinations and detection of small molecule modulators.   
This work demonstrated the application of PXCE to dimers and 
immunocomplexes; however, it may be possible to investigate more complex interactions 
using PXCE. In many cases multimeric complexes are of interest and alter protein 
function. As long as the proteins remain within the size range of gel used, it should be 
possible to detect and quantify the various complexes. PXCE may also be useful for 
studies of amyloid aggregates which have previously been investigated by CE.111,113  
Conclusion 
PXCE allows for quantifying protein-protein interaction affinities of target 
complexes including the lysozyme-anti-lysozyme immunocomplex, Hsp70-Bag3 
heterodimer and Hsp90 homodimers. CE of protein complexes that are not cross-linked, 
as in traditional APCE, can be limited by the difficulty of developing methods that 
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maintain complexes but also allow separations. Use of cross-linking allows for simplified 
method development compared to APCE by making PPIs amenable to harsh separation 
conditions and separation times longer than the typical time-scale of the PPI. This 
development should make PXCE, with the associated advantages of speed, low sample 
consumption, resolution, and quantification, applicable to a wider range of proteins and 
accessible to more labs. CE-LIF allows for sensitive detection of PPIs with the 
requirement of having binding partners be fluorescently labeled for LIF detection.      
Quantitative information can be obtained for small molecule modulators including 
fluorescent molecules suggesting that PXCE may be a valuable strategy for 
characterizing such molecules. CE, especially in microchip format, has the advantage of 
providing rapid separations, suggesting the possibility of use of PXCE for high-
throughput screening.99,169  
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Chapter 3: Protein Cross-linking Capillary Electrophoresis at Increased 
Throughput for a Range of Protein-Protein Interactions 
 
Reproduced from Ref. 170 (Ouimet, C. et al. Analyst 2018, 143, 1805) 
 with permission from the Royal Society of Chemistry. 
 
 
Introduction 
Many proteins participate in protein-protein interactions (PPIs) of varying affinities and 
complexities. Although a variety of methods for PPI analysis exist, most have limitations 
such as requiring large amounts of protein sample, utility only in a narrow affinity range, 
or suitability for analysis of only one interaction at a time. Affinity Probe Capillary 
Electrophoresis (APCE) has the potential to overcome these limitations and become a 
useful tool for measurement and screening of PPIs. In APCE, one of the binding partners 
is labeled with a fluorophore, pre-equilibrated with binding partner, and then analyzed by 
capillary electrophoresis with laser induced fluorescence detection (CE-LIF) so that free 
and bound proteins can be detected.106 APCE is an attractive platform for addressing 
challenges in PPI analysis as sample requirements are low, complexes of varying affinity 
are tractable, and the separation component provides resolution between different 
complexes.  
APCE method development for PPIs can be difficult if electrophoretic mobility 
changes upon protein binding are small, proteins adsorb to the capillary wall, or 
complexes dissociate during the separation. Protein adsorption causes irreproducibility 
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and distorts peak shapes and areas preventing accurate quantification. Conditions that 
mitigate adsorption, such as extreme pH or SDS-denaturation with sieving separation, are 
not generally compatible with native protein interactions. Complex dissociation during 
separation is problematic for transient interactions where complex dissociation occurs on 
the timescale of the separation. Identification of conditions that are suitable for separation 
and maintenance of multiple interactions is even more challenging. Quantification of 
multiple peptides binding to the same protein has been reported by CE;30 however, APCE 
of multimeric protein-protein complexes has not been reported. As a result of these 
challenges, APCE is not yet a widely used method for analysis of PPIs.  
Previously we reported a modified APCE method, termed protein cross-linking 
capillary electrophoresis (PXCE), which simplified method development and may be 
more generally applicable for PPI analysis. In this method, interacting proteins are 
covalently cross-linked prior to electrophoresis. By decoupling the binding reaction and 
separation step, it is possible to use harsh separation conditions, such as denaturing 
capillary gel electrophoresis (CGE), which can reliably resolve protein complexes based 
on size using standard conditions. The original report of PXCE used cross-linking with 
formaldehyde for 10 min and was demonstrated for analysis of dimeric PPIs with low 
nanomolar Kd values.171 As reported here, these conditions are limited to high affinity 
PPIs. An ideal method would allow for the quantification of low to high affinity PPIs as 
well as complexes that consist of higher order oligomers. Also, the method required at 
least 10 min for gel separation, limiting its throughput. 
Here we report a PXCE method capable of quantitative analysis of PPIs with low 
nM to low µM Kd values by using glutaraldehyde as the cross-linker, a reagent previously 
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demonstrated to have rapid reaction kinetics and high yields.172,173 We also demonstrate 
higher throughput CGE through use of a lower viscosity separation media and 
overlapping injections so that individual assays can be completed in 1 min. Finally we 
demonstrate the potential for analyzing multimeric complexes. The method is 
demonstrated on an array of chaperone and transcription factor proteins including heat 
shock protein 70 (Hsp70) homodimer, Hsp70-heat shock organizing protein (HOP), 
Hsp70-bcl2 association athanogene 3 (Bag3), heat shock protein 90 (Hsp90) homodimer, 
Hsp70-c-terminus of Hsp70 interacting protein (CHIP), KIX domain of CREB-binding 
protein (KIX)-E2A17, and KIX-c-Myb.  
Experimental 
 
Materials and Reagents  
All reagents were purchased from Millipore Sigma (St Louis, MO), unless otherwise 
specified. All buffers were made using 18 MΩ water deionized by a Series 1090 E-pure 
system (Barnstead Thermolyne, Dubuque, IA).  
Protein Purification and Labeling 
Hsp70 and Hsp90 were purified and labeled with AlexaFluor488 as previously described. 
171,6 Recombinant human CHIP, HOP, and HOP mutants were purified as described 
previously.174   The peptides c-Myb and E2A17 were synthesized using 9-
fluorenylmethoxycarbonyl (Fmoc) solid phase synthesis with CLEAR-Amide Resin 
(Peptides International, Inc.). c-Myb (FITC-βAla-
KEKRIKELELLLMSTENELKGQQALW-NH2) and E2A17 (FITC-βAla-
GTDKELSDLLDFSAMFS-CONH2) were FITC labeled, dried under nitrogen, 
precipitated, washed with cold ether, purified by reverse phase HPLC, lyophilized and 
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dissolved in DMSO. The KIX domain of mouse CREB-binding protein was expressed 
and purified as previously described,128  for a resulting molecular weight of 12 kDa.  
Protein Cross-linking  
Proteins were allowed to equilibrate in assay buffer at room temperature for at least 30 
min prior to cross-linking. For nucleotide state dependence experiments proteins were 
incubated with either 10 mM ATP or 10 mM ADP. For KIX-c-Myb and KIX-E2A17 
interaction the assay buffer was 10 mM sodium phosphate, 100 mM NaCl, pH 6.8. For 
Hsp70-HOP the assay buffer was 50 mM HEPES, 75 mM NaCl, 0.001% Triton X pH 
7.4. For all other PPIs an assay buffer of 25 mM HEPES, 10 mM KCl, and 5 mM MgCl2, 
pH 7.5, was utilized. Cross-linking was carried out at room temperature by a 1:20 
dilution of 40% w/v glutaraldehyde to a final concentration of 2% w/v glutaraldehyde, 
unless otherwise specified. The cross-linking reaction was quenched with 800 mM Tris 
after 10 s for a final concentration of 400 mM Tris unless otherwise stated. Lastly, SDS 
was added prior to injection to a final concentration of 0.2% w/v for sieving separations. 
Capillary Electrophoresis 
A Beckman Coulter P/ACE MDQ Capillary Electrophoresis instrument (Fullerton, CA) 
was used for all experiments. The excitation wavelength filter was 488 nm and the 
emission wavelength filter was 520 nm. Fused silica capillary (Polymicro Technologies; 
Phoenix, AZ) was 360 µm outer diameter 40 µm inner diameter unless otherwise stated. 
The total capillary length was 30 cm and the capillary length to detector was 10 cm. 
Electropherograms were acquired using 32 Karat software (Beckman Coulter), were 
analyzed using Cutter 7.0 software,31 and data were fit using GraphPad Prism 7.  
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For PXCE separations the sieving media was 180 mM tris, 200 mM borate, 1 mM 
EDTA, 13.8 mM SDS, 7% dextran (1,500-2,800 kDa), and 10% glycerol unless 
otherwise specified. Samples were introduced by hydrodynamic injection at 5 psi for 15 
s. A field of 567 V/cm was applied for separation. Capillaries were preconditioned by 
sequentially rinsing with water, hydrochloric acid, water, sodium hydroxide, water, 
UltraTrol LN (Target Discovery, Palo Alto, CA), and finally gel media. Capillaries were 
reconditioned after a noticeable shift in migration time was observed, typically after one 
hour of continuous operation.  
For affinity probe capillary electrophoresis (APCE) without cross-linking the 
capillary was conditioned sequentially with sodium hydroxide, water, and run buffer. The 
running buffer was 25 mM HEPES, pH 7.5. Samples were introduced electrokinetically 
with an applied voltage of 5 kV for 5 s. The separation field was 1,000 V/cm. The 
capillary was reconditioned between injections with sodium hydroxide followed by 
running buffer.  
For increased throughput PXCE, the sieving media was 90 mM Tris, 100 mM 
borate, 1 mM EDTA, 13.8 mM SDS, 3.5% dextran (1,500-2,800 kDa), 5% sorbitol and a 
25 µm inner diameter 360 µm outer diameter capillary with 30 cm total length and 10 cm 
to detector was used. Samples were introduced sequentially by hydrodynamic injection 
for 15 s followed by separation at 1 kV/cm. 
Size Exclusion Chromatography 
Size exclusion chromatography (SEC) was carried out on an Agilent 1100 (Santa Clara, 
CA) using a TSKgel SuperSW3000 column (Millipore Sigma) with a flow rate of 0.3 
mL/min and a sample injection volume of 1 µL. Detection was by UV absorbance at 280 
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nm. The mobile phase was 0.05% sodium azide, 0.1 M sodium sulfate, 0.1 M sodium 
phosphate, pH 6.7. Data were sampled at 20 Hz with a 14-bit data acquisition card 
(National Instruments, Austin, TX). Chromatograms were acquired using an in-house 
LabView (National Instruments, Austin, TX) program. 
Results and Discussion 
Cross-linking Conditions and Characterization of Non-specific Interactions 
It has been reported that for highly dynamic interactions, formaldehyde cross-linking is 
not effective because of an insufficiently fast reaction under certain conditions.168 If the 
cross-linking reaction kinetics are not much faster than the dissociation kinetics, then the 
fraction of complex cross-linked will be lower than that present under equilibrium 
conditions.167 Glutaraldehyde reacts rapidly at high cross-linker concentration175 which is 
expected to minimize under-cross-linking, even of transient complexes173. We 
hypothesized that such a reaction might be better able to capture complexes for a PXCE 
experiment. We tested the hypothesis that glutaraldehyde would be a sufficient cross-
linker for the highly dynamic interaction between Hsp70 and HOP which has previously 
been observed to have fast dissociation and association kinetics.176,177 We found 10 min 
of formaldehyde cross-linking was insufficient to covalently capture this interaction; 
however, a 10 s reaction with glutaraldehyde led to a large amount of complex being 
detected (Figure 3-1).  
 We then tested the effect of glutaraldehyde concentration and reaction time 
on yield of complex for three interactions with Kd values in the low µM range: Hsp70 
homodimer, Hsp70-HOP and c-Myb-KIX. These results showed that the highest yields of 
covalent complex were achieved with less than 1 min of cross-linking with 2% w/v 
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glutaraldehyde. Interestingly, for both Hsp70-HOP and c-Myb-KIX, reactions as short as 
10 s were sufficient for the highest yields of cross-linked product (Figure 3-1).  
 
 
Figure 3-1. Evaluation of glutaraldehyde cross-linking yield for low affinity PPIs. 
Comparison of yield of Hsp70-HOP complex with glutaraldehyde or paraformaldehyde 
cross-linking reactions (A). Dependence of Hsp70 homodimer (B), Hsp70-HOP (C), and 
c-Myb-KIX (D) complex yields on glutaraldehyde cross-linking time and concentration. 
 
 To further investigate the effects of cross-linking and the conditions under 
which specific interactions are favored over nonspecific interactions, SEC was employed. 
SEC mobile phase is sometimes compatible with native PPI conditions and, as a result, 
complexes can be observed without cross-linking. The high mass range of SEC also 
allows for high molecular weight aggregates resulting from nonspecific cross-linking to 
be monitored. Bag3 and HOP were chosen as model proteins to determine the cross-
linking reaction conditions that result in non-specific aggregation. Bag3 and HOP are not 
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expected to self-associate into high mass complexes154,178 and minimal aggregation was 
observed by SEC without cross-linking even at high protein concentration. With a 10 s 
cross-linking reaction however, higher molecular weight species, presumably aggregates, 
were detectable at protein concentrations of 20 µM and above (Figure 3-2A). This result 
suggests an upper limit to protein concentrations that can be studied using this method. 
Non-specific interactions have been reported to dominate in this concentration range 
potentially due to the presence of non-specific interactions between proteins. For 
example, with NHS ester cross-linking, non-specific complexes were observed at protein 
concentrations at 40 µM167 and at 33 µM179. 
 
 
 
Figure 3-2. High molecular weight aggregates of Bag3, HOP, and Hsp70 observed by 
glutaraldehyde by size exclusion chromatography. Effect of protein concentration (A) on 
observation of high molecular weight aggregate after 10 s of glutaraldehyde cross-
linking. Effect of increasing cross-linking reaction time on high molecular weight 
aggregates (B) protein concentration was 10 µM. 
 
 Besides high protein concentrations, we also considered the possibility that 
long cross-linking times could lead to additional aggregation. It has previously been 
reported that glutaraldehyde cross-linking is specific only at short reaction times180. At 10 
µM, Bag3 and HOP were not found to aggregate even at long cross-linking reaction 
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times. Hsp70, however, was found to exhibit increasing aggregation by SEC at cross-
linking times greater than about ~70 s (Figure 3-2B). Slow, higher order aggregation of 
Hsp70 has been observed previously181,182, potentially explaining the increase seen at 
long cross-linking times. This result explains previous observations of decreasing yields 
of complex at long cross-linking reaction times with formaldehyde cross-linking 
PXCE.171 That is, higher molecular weight aggregates are preferentially excluded from 
the gel during injection this preventing detection and the result is observation of low 
complex formation. This effect likely explains the apparent drop in complex yield in the 
PXCE experiments at longer reaction times (600 s) in Figure3-1C,D. To minimize the 
effects of non-specific or additional high mass aggregation, we limited our assays to total 
protein concentrations of 20 µM or less with cross-linking reaction times of 10 s. These 
conditions circumscribe the assay to PPIs with low µM or lower Kds where saturation 
binding experiments can be completed without using overly high concentrations of 
protein, circumventing the need to subtract nonspecific cross-linking to determine 
binding affinity. 
Determination of PPI Affinity 
We next determined if 10 s reactions with proteins below 20 µM would be sufficient for 
quantification of binding affinity for a variety of PPIs. For these experiments, saturation 
binding curves were carried out by PXCE on PPIs with low µM to low nM Kd values 
(Figure 3-3).  
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Figure 3-3. Electropherograms and saturation binding curves for µM to nM affinity 
complexes by 10 s glutaraldehyde cross-linking PXCE. Saturation binding curves were fit 
by nonlinear regression to find Kd = 3.1 ± 0.5 µM, 3.8 ± 0.7 µM, 1.2 ± 0.3 µM, 26 ± 6 
nM, 2.1 ± 0.3 nM for FITC-c-Myb-KIX (A), Hsp70*-HOP (B), Hsp70* homodimer (C), 
Hsp70*-Bag3 (D), and Hsp90* homodimer (E), respectively. The first peak in the 
Hsp70* electropherograms corresponds to a low molecular weight impurity. 
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 Good agreement was found between the Kd values determined by PXCE 
and values reported by non-cross-linking methods for Hsp70-Bag3, Hsp90 homodimer, 
Hsp70 homodimer, Hsp70-HOP, and KIX-c-Myb (Figure 3-4, Table 3-1). We conclude 
that PXCE with 10 s glutaraldehyde cross-linking time is sufficient for measuring the 
affinities of these complexes for Kd values spanning three orders of magnitude from low 
nM to low µM values.  
 
 
Figure 3-4. Comparison of PXCE Kd values from data in Figure 2 to Kd values from non-
cross-linking methods for Hsp90 homodimer162, Hsp70-Bag36, Hsp70 homodimer181, 
Hsp70-HOP174, and FITC-c-Myb-KIX. 
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Table 3-1. Comparison of PXCE and Literature Kd values for µM to nM PPIs. 
Protein Interaction Kd PXCE Kd Literature 
c-Myb-KIX 3.1 ± 0.5 µM 1.6 ± 0.2 µM 
Hsp70-HOP 3.8 ± 0.7 µM 2.7 ± 0.4 µM174 
Hsp70 homodimer 1.2 ± 0.3 µM 11 µM181 
Hsp70-Bag3 26 ± 6 nM 23 ± 8 nM6 
Hsp90 homodimer 2.1 ± 0.3 nM 1.29 nM162 60 ± 12 nM161 
 
 
Sensitivity of Assay to Point Mutations and Nucleotide State 
We next determined the sensitivity of the glutaraldehyde PXCE method to changes in 
protein structure by measuring the effect of binding site point mutants and the nucleotide 
state on interaction affinity. Hsp70 is an ATPase known to undergo nucleotide state 
dependent structural changes leading to changes in the degree of homo-
oligomerization.181,183 Here, clear differences in homodimerization affinity were seen for 
Hsp70 with the ATP state having the weakest affinity and the ADP state having the 
greatest affinity for homodimerizing (Figure 3-5). The sensitivity of the PXCE assay to 
such structural changes lends further evidence to the specificity of this method. 
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Figure 3-5. Sensitivity of 10 s glutaraldehyde cross-linking assay to nucleotide 
dependent homodimerization of Hsp70*.  
 
 HOP proteins with one-site substitution mutations in the Hsp70 binding site 
were also investigated. HOP with mutations R77A and N223A inhibit the interaction of 
HOP with Hsp70.174 Using a 10 s glutaraldehyde cross-linking reaction the wild type 
protein had a lower Kd value than the mutants, as expected (Figure 3-6). In fact, the rank 
order for the Kd values of the two mutants was in agreement between PXCE and values 
obtained using fluorescence polarization174. The R77A mutant HOP however, was found 
to have a much higher Kd value by fluorescence polarization (>25 µM) than by PXCE (3 
± 1 µM), indicative of a much lower apparent affinity for Hsp70 by fluorescence 
polarization compared to PXCE. Notably, the PXCE assay was carried out on full length 
proteins while the fluorescence polarization assay was of the interaction between full 
length HOP and a peptide consisting of the EEVD domain of Hsp70.  
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Figure 3-6. Sensitivity of 10 s glutaraldehyde cross-linking assay to point mutants of 
HOP. Saturation binding curves (A) and comparison to APCE and fluorescence 
polarization 174 data (B). 
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 Two potential explanations for the discrepancy in Kd values between the 
fluorescence polarization and PXCE assays were explored: 1) The PXCE Kd is an artifact 
of cross-linking and 2) Full length Hsp70 has a higher affinity for HOPR77A than does 
the EEVD domain alone. The affinity of full length Hsp70 for HOPR77A was confirmed 
by APCE without cross-linking (Kd = 4 ± 2 µM, Figure 3-7) suggesting that the Kd 
measured by PXCE was not a cross-linking artifact.  
 
 
Figure 3-7. APCE electropherograms (A) and saturation binding curve for Hsp70-HOP 
interaction without cross-linking (B).  
 
 
To compare the affinities of full length Hsp70 and the EEVD domain alone for 
HOPR77A a competitive binding experiment was carried out (Figure 3-8). Full length 
Hsp70 was found to have higher affinity for HOPR77A than either the EEVD domain or 
the full-length form of Hsp70 with a deletion in the EEVD domain. This result is in 
agreement with other reports which have found the EEVD domain to be important for the 
Hsp70-HOP interaction while not accounting for all of the affinity.174,177 Compatibility 
with full length protein is an advantage of this CE assay as use of full length protein 
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eliminates the method development or artifacts associated with use of peptide necessary 
for fluorescence polarization. 
 
Figure 3-8. Comparison of increasing concentrations of unlabeled Hsp70 constructs 
binding to 1 µM HOPR77A in the presence of 100 nM Hsp70*.  
 
Increased Throughput Electrophoretic Sieving Separation 
In view of the apparent utility of the method for measuring affinities for a wide range of 
PPIs, we sought to improve the throughput of the method. Although microchip CE and 
other techniques can achieve separations in seconds, in this case we used a commercial 
CE instrument to maintain accessibility to a wider range of potential users. Decreasing 
the viscosity of the sieving media was seen as a key to improving throughput because it 
both allows faster migration at a given electric field and allows smaller bore capillaries to 
be used. Higher fields can be applied without detrimental heating effects by use of lower 
diameter capillary; however, with viscous sieving matrix it can be difficult to rinse the 
matrix through small bore capillaries. Use of ultralow viscosity sieving matrices have 
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been reported for DNA separations184,185 and are compatible with rapid capillary 
regeneration. Here, an ultralow viscosity sieving matrix (7.45 ± 0.05 cP) was utilized for 
protein separation. This matrix is about 1/5th as viscous as the matrix used above however 
sufficient separation of 11-155 kDa proteins was maintained (Figure 3-9). The ultralow 
viscosity matrix can be rinsed through a 25 µm capillary in 5 min (at 50 psi > 3 capillary 
volumes are replaced) while the higher viscosity matrix would require 26 min to be 
rinsed through a 25 µm capillary. Using the ultralow viscosity matrix, a 1 kV/cm field 
can be applied in a 25 µm capillary without observing the heating effects that were 
observed in 40 µm capillary (Figure 3-10). This high field allows for 11-155 kDa 
proteins to be separated in 2 min (Figure 3-9).  
 
Figure 3-9. Separation of 11, 21, 32, 40, 63, 98, and 155 kDa protein ladder 
(BenchMarkTM Fluorescent Protein Standard, Life Technologies, Carlsbad, CA) on low 
viscosity sieving matrix at 1 kV/cm at 10 cm effective separation length. 
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Figure 3--10. Ohm’s plot of low viscosity sieving matrix in 40 µm or 25 µm capillary.  
 
 
 It is possible to further increase the throughput of sequential injections by 
overlapping the injections based on the separation window and the time that occurs prior 
to the first peak in the separation.186 By using overlapping injections on a 25 µm capillary 
with the ultralow viscosity sieving matrix it was possible to make sequential injections 
and separations with a throughput of 1 sample/min (Figure 3-11). The samples could be 
repeatedly injected for up to about 70 min before the capillary needed rinsing. Saturation 
binding curve data was obtained from this electropherogram and a Kd for the binding 
interaction was determined to be 1.1 ± 0.2 µM (Figure 3-11C), in good agreement with 
the Kd value obtained by fluorescence polarization of 1.1 ± 0.2 µM. This strategy could 
also be used for determination of small molecule PPI inhibitor potency. A dose response 
curve for Hsp70-Bag3 inhibitor JG-98 was carried out using overlapping injection for 8 
samples in 10 min for a single replicate. A log(IC50) value of -6.4 ± 0.1 was determined 
(Figure 3-11F) which is in good agreement with the previously reported log(IC50) value 
of -6.1 ± 0.3 showing good accuracy of the method.171  
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Figure 3-11. Overlapping injections for saturation binding curve and IC50 determination 
at increased throughput. Electropherogram of continuous overlapping injections of 
samples at various KIX concentrations (A). A section from 28 to 32 min of the 
electropherogram with analytes from injection of four different samples (B). 
Determination of the Kd value for the E2A17-KIX interaction from the electropherogram 
shown in A (C). Electropherogram of continuous overlapping injections of Hsp70-Bag3 
and fluorescent small molecule inhibitor JG-98 (D). A section of the electropherograms 
corresponding to analytesfrom one injection. Determination of IC50 for Hsp70-Bag3 
complex inhibition by JG-98 (F). 
 
Application to Higher Order Oligomers 
Many of the proteins discussed here form additional higher order or multi-protein 
complexes. To determine the utility of this method for application to higher order 
oligomers, the binding of Hsp70 to CHIP was investigated. At 0.5 µM Hsp70 in the apo 
nucleotide state both monomeric and dimeric Hsp70 are observed. Upon addition of 1 
µM CHIP a 2:2 Hsp70:CHIP complex was evident (Figure 3-12). Previous reports of 
Hsp70-CHIP complex have found similar results with CHIP forming a homodimer and 
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binding to two Hsp70 to form a 210 kDa complex.122,187 This result demonstrates the 
potential utility of this method for the investigation of multimeric complexes. Most 
methods for PPI analysis, such as isothermal calorimetry (ITC) and fluorescence 
polarization, are incompatible with resolving multiple interactions in a single assay. 
 
 
Figure 3-12. Electropherograms of multimeric complexes Hsp70apo:CHIP. Hsp70* 
concentration is 1 µM (both traces) and CHIP concentration is 4 µM (black track). 
Molecular weight was calculated based on size standards.  
 
Conclusions 
With a fast (10 s) cross-linking reaction, protein complexes with Kd values spanning 3-
orders of magnitude, from low nM to low µM, could be quantified by PXCE. The 10 s 
cross-linking reaction is 60-fold faster than the previous cross-linker used for PXCE. The 
presence of possible non-specific aggregation at high protein concentrations limits the 
practical applicability of this method to investigations of low µM or lower Kd values. The 
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molecular weight range of the gel matrix used also limits the method to complexes less 
than 250 kDa. There is potential to further tune the size limit of the gel as has been 
demonstrated for other entangled polymer gel matrices.188 
This method has a number of advantages over other PPI analysis methods. PXCE 
is compatible with full-length proteins eliminating the need to prepare short peptide 
mimics of the protein, as is often necessary in fluorescence polarization assays. The 
ability to distinguish multiple complexes suggests that this method will be useful for 
evaluating the specificity of a PPI inhibitor as has previously been demonstrated for 
protein-peptide interactions30. By using overlapping injection methods the separation 
time can be decreased to about 1 min per sample suggesting potential utility of the 
method when higher throughput is necessary. Dissociation constants and IC50 values can 
each be determined in about 10 min compared to hours required by other methods such as 
ITC. There is potential for further increasing throughput by using 96- or 384-capillary 
arrays or microchip electrophoresis. 
  
	 69	
 
 
 
 
 
 
 
Chapter 4:  Towards High Throughput Protein Cross-linking Microchip 
Electrophoresis 
 
 
 
Introduction 
 
Capillary electrophoresis (CE) has demonstrated utility in screening for modulators of 
enzymes and protein-protein interactions.2,189 CE has demonstrated low false positive 
rates in screening6 because it directly detects reactants and products and discriminates 
against potential sources of interference including optically active test compounds2,4,6, 
non-specific protein aggregation6 and test compound precipitation6. For electrophoresis to 
reach throughputs compatible with screening large chemical libraries, rapid separations 
are required. Microchip electrophoresis (MCE) can provide separations on the timescale 
of milliseconds for free-solution electrophoresis19 and seconds for gel electrophoresis190, 
however, one of the biggest limitations to throughput is achieving sample introduction at 
commensurate throughput. For microchip electrophoresis, samples are typically manually 
loaded into reservoirs on the device limiting the actual throughput achievable for multiple 
samples. One exception is the commercial LabChip instrument (Perkin Elmer). This 
instrument introduces samples to a microchip directly from a multiwell plate, affording a 
throughput of about 1 min per sample.   
Beyond commercial instrumentation, automated sample introduction has been 
reported using droplet microfluidics approaches.64,65,67–69,73 In these methods, samples are 
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contained within nanoliter volume aqueous droplets and separated from one another by 
an immiscible carrier phase. The low volume droplets are sequentially introduced into an 
aqueous separation channel for electrophoresis. While this strategy can provide rapid 
automated sample introduction, injection of immiscible, non-conductive segmenting 
liquid is incompatible with electrophoretic separations. Introduction of carrier phase may 
cause electroosmotic flow instability and plug formation leading to shorting and 
dielectric device breakdown.64,65,71  
A number of devices have been reported for coupling droplets to electrophoresis 
without introducing the segmenting phase to the electrophoresis channel 17,64,65,68,69,72. 
These devices rely on surface patterning17,64,65,72, modified channel geometries 68 or use 
of an oleophilic membrane 73. While most devices have been demonstrated with 
throughputs on the order of ~1 min/sample, one device has been used to perform high 
throughput screening of enzyme modulators at 2 s/sample, however, this device is limited 
to performing free solution electrophoresis.18 In fact, most devices have been 
demonstrated for compatibility with free solution electrophoresis alone. There is only one 
report of coupling droplets to gel electrophoresis. In this design, an oleophilic membrane 
was used to extract the carrier phase from the droplet stream while the entire droplet was 
injected into the separation channel. This was demonstrated for gel electrophoresis using 
a hybrid PDMS fused silica device and using a PDMS device for free-solution 
electrophoresis with separation times of about 60 s and 30 s per sample, respectively.73 In 
this device, resolution was sacrificed due to injection of relatively large sample volumes. 
Here, we report a chip for coupling droplets to gel and free solution 
electrophoresis, which allows controlled injection size for rapid and high efficiency 
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separations. Separation time for gel electrophoresis of proteins achieved in 2.5 s, a 
significant improvement over our previously reported 1 min/sample separation time170 
with high resolving power compared to previous reports of sieving electrophoresis on the 
second timescale191. The utility of the device is demonstrated for both enzyme and 
protein-protein interaction (PPI) samples at a throughput of ~10 s per sample with 
multiple injections per sample. 
 
Experimental 
Chemicals and Materials  
Proteins were expressed, purified, and labeled as previously described.18,171 BenchmarkTM 
fluorescent protein standard ladder was purchased from Life Technologies (Carlsbad, 
CA). Chemicals and reagents were purchased from Sigma-Aldrich, Saint Louis, MO, 
unless otherwise stated. 
Device Fabrication 
Glass (Telic Company, Valencia, CA) was fabricated by photolithography and etching 
with hydrofluoric acid as previously described192–194. For the capillary insertion channel 
both top and bottom slides are etched to 75 µm. For separation channels, the top slide is 
etched to 8.8 µm. Access holes were drilled in the top slide with 400 µm drill bits 
(Kyocera Precision Tools, Henderson, NC). Both slides were aligned under microscope 
such that insertion channels on each slide are flush. Chips were thermally annealed at 610 
˚C for 8 h. Subsequently, reservoirs and fused silica capillary 150 µm o.d. 75 µm i.d. 
(Polymicro Technologies; Phoenix, AZ) were secured to the device using Loctite Epoxy 
Marine (Loctite, Düsseldorf, Germany).  
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Microchip Operation 
For imaging an Olympus IX71 (Tokyo, Japan) fluorescence microscope was used. For all 
other experiments a previously described in-house confocal laser-induced fluorescence 
(LIF) detector was used.17 A 488 nm laser (CrystLaser, Reno, NV) was used for 
excitation with emission filtered through a 520 nm filter. Data were analyzed using Cutter 
7.0 31 and Graphpad Prism 7.  
Free-solution Microchip Electrophoresis 
For free-solution electrophoresis Rain-X (ITW Global Brands, Houston, TX) was pulled 
by vacuum through the fused silica capillary for 1 min to coat the inner surface of the 
capillary and facilitate droplet transfer. Reservoirs were then filled with 10 mM sodium 
tetraborate, 0.9 mM 2-hydroxypropyl-β-cylcodextrin, pH 10 and vacuum was applied at 
the waste reservoir for at least 5 min to fill all channels with this running buffer. For 
separation, 800 V/cm was applied with 100 ms gated injections195 every 900 ms. The 
separation length to detector was 3 mm. 
Microchip Gel Electrophoresis 
For gel electrophoresis, microchips were conditioned sequentially with 1 M sodium 
hydroxide, water, ultratrol LN (Target Discovery, Palo Alto, CA) and water by pulling 
vacuum at the waste reservoir. Rain-X was then pulled through the fused silica capillary 
by applying vacuum at the sample reservoir for 1 min. Next, all channels were filled with 
air by applying vacuum until all channels were observed to be empty. Finally, gating and 
sample reservoirs were filled with gel and vacuum was applied at the waste reservoir to 
fill all channels with gel. Sieving matrix used was 90 mM Tris 100 mM borate, 1 mM 
EDTA, 13.8 mM SDS, 3.5% dextran (1,500-2,800 kDa). Gated injections were carried 
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out every 100 ms, separations were at 1,200 V/cm, and detection was at 3 mm, unless 
otherwise stated.  
Droplet Generation and Introduction to Microchip 
Droplets were generated from a multiwell plate into 360 o.d. 150 i.d. PFA Plus teflon 
tubing (Idex Health & Science, Oak Harbor, WA) as previously described 44 with the 
following exceptions: a flow rate of 0.3 µL/min was used and the carrier phase was 
silicone oil (10 cSt). The train of droplets was then connected to the microchip by 
threading the 150 µm o.d. fused silica capillary into the lumen of the teflon tubing. The 
junction was then secured using Crystal Wax (ULTRA TEC, Santa Ana, CA) to prevent 
leaking. 
Droplet Analysis of Enzyme Samples 
SIRT5 enzymatic reactions were carried out in 10 µL reaction volume with 45 nM 
SIRT5, 1 µM substrate peptide, 10 mM Tris, 1 mM DTT, 0.5 mM NAD+, 4.5 % (v/v) 
glycerol, 30 mM NaCl, and 2 mM sodium phosphate. Reactions were allowed to proceed 
for 15 min prior to quenching with 45 µL of free solution electrophoresis running buffer 
(described above).  
Droplet Analysis of Protein-Protein Interaction Samples  
Hsp70-Alexafluorophore 488 (Hsp70*) and Bag3 samples were prepared in 25 mM 
HEPES, 10 mM KCl, 5 mM MgCl2, 10 mM ATP, pH = 7.5. Proteins were cross-linked 
as previously described.170 Briefly, proteins were allowed to equilibrate at the desired 
concentration for at least 15 min prior to cross-linking with glutaraldehyde to a final 
concentration of 2% for 10 s prior to quenching with Tris to a final concentration of 400 
mM.  
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Results and Discussion 
Microchip Gel Electrophoresis 
Microchip electrophoresis allows short separations lengths and high electric fields to be 
readily accessed enabling decreased separation times relative to conventional CE. Rapid 
MCE separations have potential to analyze large numbers of samples at high throughput. 
Figure 4-1 demonstrates the separation of standard protein ladder in less than 2.5 s by 
SDS-microchip gel electrophoresis. A similar separation by microchip gel electrophoresis 
was reported with a separation time of 2.7 s achieved resolution of 1.66 between 22 and 
67 kDa proteins.191 Resolution of 5.3 between 21 and 63 kDa proteins was achieved in 
this case. The higher resolution achieved is attributed to the longer separation length and 
higher electric field along with differing sieving media and device material. 
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Figure 4-1. SDS-microchip gel electrophoresis separation of 11, 21, 32, 40, 63, 98 and 
155 kDa standard protein ladder on microchip with 70 separations overlaid. Separation 
length was 3 mm and electric field was 800 V/cm.  
 
Further, the separation tolerated repeated injections without reconditioning of the 
microchip. Up to 1,250 injections and separations were carried out on a single device 
without reconditioning. This result suggests utility of this separation for high throughput 
sample analysis if injection of sequential samples could be performed at equivalent 
throughput. While several reports of rapid gel electrophoresis separations exist169,190,191 
none have demonstrated sample introduction throughput needed to fully take advantage 
of such rapid separations. 
Previously, throughputs of ~1 min/sample were achieved for separation of 
standard protein ladders using commercial CE170 and microchip instrumentation169. These 
instruments are compatible with injection from multiwell plate; however, commercial 
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instrumentation is often limited to fixed separation distances limiting potential for faster 
separations. To take advantage of the rapid separation reported here automated sample 
introduction is required.  
 
Operation of Density Based Oil Drain 
 
To couple droplets to microchip electrophoresis, complete extraction of the oil from the 
droplet train is necessary. Removal of oil from droplet train was performed by taking 
advantage of the density difference between the segmenting phase (ρoil) and the 
background electrolyte (ρBGE) (Figure 4-2). Silicone oil was chosen as the segmenting 
phase for its relatively low density (0.93 g/mL). Other lower density oils, such as light 
mineral oil caused difficulties in droplet generation likely due to relatively higher 
viscosity (data not shown).  
 
Figure 4-2. Schematic of cross-section of density based oil drain microchip. Nanoliter 
volume droplets are pumped into the device and the low density segmenting phase 
(yellow) drains to the top of the buffer filled reservoir (blue) where high voltage (HV) is 
applied. Aqueous droplets merge with the buffer and analytes are electrophoresed toward 
grounded reservoir (not shown). 
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The train of droplets is driven into the microchip via syringe pump. The train first 
enters the fused silica transfer capillary which directs the droplets into the area beneath a 
reservoir filled with background electrolyte. As the droplet train is flowed into the device 
the segmenting phase, which is immiscible with and less dense than the background 
electrolyte, pools at the outlet of the transfer capillary and floats to the top of the buffer-
containing reservoir. This observation is consistent with the net buoyancy force (Fnet) 
being able to overcome the force of gravity (g) once a certain volume of oil displaces the 
running buffer (Vdisplaced) at the outlet of the transfer capillary (equation 4-1). 
Fnet = Vdisplaced g(ρBGE- ρoil)               (Eq 4-1) 
 High voltage was continuously applied at the oil removal reservoir such that 
upon exiting the transfer capillary the droplet coalesces with the background electrolyte 
and the contents are electrophoresed toward the grounded waste reservoir (Figure 4-5A). 
Importantly, the outlet of the droplet transfer capillary and the inlet of the separation 
channel are on the same plane such that the analytes migrate minimal distance to enter 
the separation channel. This geometry was designed to minimize the dead volume prior to 
electrophoresis. After analytes enter the channel they reach the injection cross where 
gated injection affords control of injection size. As sample reaches the injection cross, 
discrete injections can be made from each sample droplet (Figure 4-3B). 
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Figure 4-3. Fluorescence imaging of droplet introduction. Droplet exits fused silica 
capillary and is electrophoresed towards injection cross. Clearing of droplet sample is 
observed (A). Droplet content is then gated or injected to separation channel (B). 
 
In this design, the number of injections made from each droplet was dependent on 
the volume of the droplet, the separation time, and the electric field applied. Injection 
volumes were ~40 pL, corresponding to 5% of separation channel volume. Once the 
droplet coalesces with the background electrolyte the analytes begin to migrate towards 
the injection cross where a controlled fraction of the droplet is injected. To obtain 
multiple picoliter injections from each droplet, each sample was converted into 3 nL 
sample droplets. During injection, the high voltage at the gating reservoir is floated to 
allow for a discrete low volume plug of sample to be injected. To maximize throughput 
and the number of injections per sample, the timing of the injections was determined by 
the minimum separation time required. A series of injections from the same droplet 
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showed varying intensity likely resulting from sampling from the droplet as it passes the 
injection cross is depicted in Figure 4-4.  
 
 
Figure 4-4. Signal from droplet introduction for microchip gel electrophoresis 
immediately downstream of injection cross. Injections of 2 µM FITC-insulin were carried 
out every 1.3 s with detection directly downstream of injection cross.  
 
The electric field applied controls the time required for a sample droplet to clear 
the injection cross. To facilitate rapid clearing of samples and subsequently maximize 
throughput the highest accessible electric field is preferred. In this system, for microchip 
gel electrophoresis, the maximum electric field allowed without causing detrimental 
heating effects was determined by Ohm’s plot to be approximately 1,200 V/cm (Figure 
4-5). This high electric field was used in order to maximize the rate of droplet clearing 
and separation throughput.  
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Figure 4-5. Ohm’s plot for microchip gel electrophoresis. Linearity (R2 = 0.998, 
y=(1.56±0.03)x10-2 x+(0.4±0.3)) was observed up to 1,200 V/cm.  
 
 
Microchip Gel Electrophoresis of Droplets 
To determine if the density oil drain was compatible with the fast microchip gel 
electrophoresis separation of protein-protein interaction samples, droplets containing 
Hsp70 and Bag3 were generated and analyzed. Separation of the protein complex 
(Hsp70*-Bag3) from free protein (Hsp70*) has been completed in 3 min using CZE6 and 
1.25 min by CGE separation with protein cross-linking170. This PPI could be separated in 
2 s by microchip gel electrophoresis (Figure 4-6B). Overlapping injections were used to 
minimize separation time and allow for the greatest number of injections per droplet 
sample. In this approach, injections and separations are overlapped such that the peaks 
from the first injection migrate past the detector after the second injection has been made. 
While this approach is most common with capillary electrophoresis, where separation 
times tend to be longer, here we also applied overlapping injections to improve 
throughput of microchip gel electrophoresis.  
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To determine how the device would perform for multiple samples, droplets of 
alternating concentrations of Bag3 were introduced into the device. The complex peak 
area was quantified as a percentage of total peak area to account for the variations in 
intensity observed over time (Figure 4-6A). This change in intensity could be attributed 
to instability in the laser source, change in conductivity over time caused by introduction 
of sample matrix to chip, and injection occurring at various intensities along the 
introduced droplet plug (Figure 4-4). A total of 630 separations of 175 sets of sample 
droplets were analyzed without reconditioning of device for a throughput of 
approximately 10 s/sample. This is an improvement in separation throughput of 30-fold 
and a sample throughput improvement of 6-fold compared to a previous droplet-
microchip gel electrophoresis device. Further this previous device was shown to have 
decreased performance over just three separations.73  
Alternation in samples entering the chip was evident from quantifying the percent 
complex for each sample (Figure 4-6C,D). In the transition between high and low Bag3 
concentration, some data points corresponding to intermediate complex were observed 
before the complex area stabilized (Figure 4-6D). This result may be attributed to the 
discontinuous nature of the droplet injection and mixing between droplets. One possible 
source of carry-over is the fused silica transfer capillary. In future device designs this 
could be eliminated allowing direct transfer of droplets from the Teflon tubing to the oil 
removal reservoir. Another possibility is that sample does not completely clear the 
injection cross before the next sample enters. This effect could potentially be mitigated 
with larger spacing between droplets, the incorporation of dedicated wash droplets, 
smaller volume droplets, or higher electric fields.  
	 82	
 
 
Figure 4-6. Electrophoresis and performance of density-based oil drain for analysis of 
Hsp70*-Bag3 samples by microchip gel electrophoresis. Concatenated electropherograms 
of 630 separations (A,B). Quantification of relative percent Hsp70*-Bag3 complex 
present in each electropherograms (C,D). 
 
Nevertheless injections resulting from clearing between samples may be easily 
detected. Cataloguing of droplet samples was previously demonstrated for a device used 
in enzyme screening. In that work an internal standard was incorporated into alternating 
samples to deconvolute the data and select data from appropriate electropherograms.17 A 
similar strategy was employed to investigate the utility of the device for analysis of 
known small molecule Hsp70-Bag3 inhibitors. In this case, separations were catalogued 
based on presence or absence of additional, rapidly migrating peak corresponding to 
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fluorescent small molecule (Figure 4-7A). Data were normalized to positive (no target 
Bag3) and negative control (JG-258) and results for known inhibitor test compounds 
were analyzed (Figure 4-7B). Inhibition was detected for all compounds (JG-231, JG-
311, rolitetracycline, YM-01, and JG-98) which were previously known to inhibit the 
Hsp70*-Bag3 interaction. The high degree of inhibition shown by JG-311 (>100%) 
suggests potential interference of Hsp70 homodimerization in the positive control 
sample. Interestingly, large differences in the degree of inhibition by these compounds 
was detected, with JG-311 and JG-98 exhibiting the greatest inhibition. JG-311 and JG-
98 have been reported to have lower IC50 values than rolitetracycline, YM-01 and JG-
231.6,164,171 The differences in degree of inhibition may be attributed to the relatively high 
protein concentrations resulting in low degrees of inhibition for weaker inhibitors. 
 
Figure 4-7. Demonstration of small molecule Hsp70-Bag3 screening using density drain 
microchip. Indexing of samples using fluorescent small molecule internal standard (IS) 
(A). Percent inhibition determined for droplet samples containing potential small 
molecule Hsp70*-Bag3 interaction inhibitors (B). 
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Free-Solution Microchip Electrophoresis of Droplets 
To determine if the density based oil drain device was compatible with free-solution 
microchip electrophoresis, separation of Sirtuin 5 catalyzed desuccinylation of succinate 
dehydrogenase based substrate from desuccinylated product was performed based on 
previously described assay18. SIRT5 is, to date, the only known enzyme for lysine 
desuccinylation196, regulating the mitochondrial lysine succinylome197. SIRT5 has been 
demonstrated as responsible for cancer cell growth in non-small cell lung cancer198 and is 
therefore an interesting screening target. Droplets of alternating sample content (with and 
without enzyme) were generated and electrophoresed (Figure 4-8). A total of 1,250 
separations were performed without reconditioning of microchip with 160 sets of sample 
droplets analyzed. The average reaction yield measured for the sample containing 
enzyme was 49 ± 5 % across all droplets analyzed.  
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Figure 4-8. Electrophoresis and performance of density-based oil drain for analysis of 
SIRT5 reaction samples by free-solution microchip electrophoresis. Concatenated 
electropherograms of 1,250 separations (A,B). Quantification of reaction yield derived 
from each electropherogram (C,D). 
 
This separation was previously reported for screening of SIRT5 modulators using 
a hybrid PDMS-glass device with droplets extracted from the aqueous stream at the 
interface to the PDMS.18 A throughput of ~10 s/sample was obtained using the density 
based oil drain in comparison to the reported throughput of 2 s/sample reported with the 
hybrid PDMS-glass device.18 Separation time of 900 ms was achieved compared to a 250 
ms separation time reported previously when a shorter separation length and higher field 
were employed. Chips were etched to 8.8 µm whereas in previous report chips were 
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etched to 3 µm. This lower depth allowed for higher fields to be applied without 
detrimental heating effects, however, considerations of conditioning time and potential 
for clogging favor the current device design. Fabrication of the density based oil drain 
requires fewer steps and requires fewer connections compared to the hybrid device 
design.  
Limitations and Considerations 
 
Several limitations inherent to the density-based oil drain device exist including 
sensitivity to sample matrix, decreased signal compared to bulk injection methods, and 
limited compatible carrier phases. The performance of this device is highly dependent on 
the droplet sample matrix. Salty sample matrices will increase conductivity of the 
background electrolyte causing an increase in current over continuous operation of the 
chip. This is a limitation of all currently reported devices for coupling droplets to 
electrophoresis. This limits device application either to low numbers of salty droplet 
samples or to samples where the sample matrix matches the background electrolyte. 
An approximately 10-fold lower signal was observed when introducing samples 
via nanoliter volume droplets compared to introducing samples by manually filling a 
reservoir with microliter volumes of the same sample (Figure 4-9). This result may be 
attributed to dilution of the droplet sample in background electrolyte upon introduction to 
the device as well as electrokinetic injection of bulk sample allowing for injection of a 
larger number of total analytes available in the much higher volume sample. The device 
was limited to analysis of low micromolar FITC-protein concentrations.  
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Figure 4-9. Comparison of signal obtained from injection of bulk sample to injection 
from droplet samples containing 500 nM Hsp70* diluted in water.  
 
The current design is limited to use with carrier phases with lower density than 
the background electrolyte. Often fluorinated carrier phases are preferred for their inert 
properties and low partitioning of many analytes. Fluorinated carrier phases have 
relatively high densities which would allow them to be separated from a lower density 
background electrolyte by modification of the current device design. This is appealing for 
future applications of this device where molecules that are soluble in silicone oil may 
transfer between droplets. 
 
Conclusions 
This work demonstrated a novel method for coupling droplets to microchip separations 
by removing the carrier phase based on its density. The density-based oil drain was 
compatible with both sieving and free solution electrophoresis with throughput of about 
10 s/sample. Interference of segmenting oil with electrophoresis was not observed for up 
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to 175 samples analyzed. Similar to other devices, the operation is sensitive to sample 
matrix effects, limiting the number of samples that can be analyzed without 
reconditioning. The utility of this device was demonstrated for protein-protein interaction 
and enzyme assay samples suggesting future utility in screening of diverse targets.  
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Chapter 5: Future Directions 
 
This thesis has described a method for investigating protein-protein interactions by 
capillary electrophoresis with high throughput separations demonstrated using microchip 
electrophoresis. Using the PXCE method described here, many PPIs can be studied using 
CE with minimal method development. Separation times of 1 min, using commercial CE 
instrumentation, and 2.5 s, using microchip electrophoresis were demonstrated for 
separation of PPIs. Further, a method for fast, automated, sample introduction using 
droplet microfluidics allowed for throughputs of 10 s/sample for free solution and gel 
electrophoresis separations. While these results suggest this platform may have utility in 
screening, a large scale screen has yet to be performed using this platform.  Further, the 
presented methods are still limited by sample introduction throughput, required labeling 
of one of the protein-binding partners, and necessitated microliter sample volumes. 
Opportunities for improved throughput, label-free and small volume assays are proposed.  
Improving Throughput for Microchip Electrophoresis of PPIs 
While Chapter 4 presented a method for automating sample introduction to improve 
assay throughput the separation times achievable by microchip electrophoresis remain 
faster than the sample introduction throughput achieved. Fast sample introduction could 
also be achieved by incorporation of multiple sample reservoirs per device or 
parallelization of separation channels.  
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Devices with multiple sample reservoirs from which injections could be made 
have been reported. This strategy allows for rapid switching between samples, a process 
that could be easily automated. To demonstrate the utility of this approach for protein-
protein interaction samples a microchip with 5 sampling reservoirs and a single 
separation channel was fabricated (Figure 5-1A). Injections from each sample reservoir 
could be made sequentially simply by switching which sample reservoir was held at high 
voltage (Figure 5-1B). This strategy eliminates the need to reformat samples into 
droplets prior to electrophoresis. As demonstrated in figure 5-1, such a device is ideally 
suited for assays requiring <10 samples such as for Kd, Ki, or IC50 determination.  
 
Figure 5-1. Schematic of electrophoresis device for introducing five samples in the same 
device (A). Use of device for Kd determination (B and C).  
 
To further improve throughput a device with multiple separation channels could 
be fabricated. Parallelization affords increased throughput by allowing multiple 
separations to be performed simultaneously. A parallel density oil drain system may be 
possible for high throughput analysis of a large number of droplet samples (Figure 5-2). 
Detection on a parallelized device can be achieved by fluorescence imaging.22 
Incorporation of three separation channels on a single device triples the throughput in 
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comparison to a single channel device. Further, the number of droplets that can be 
produced in a single train is limited. This device would allow for a 3-fold increase in the 
number of droplets that could be analyzed in a single run.  
Previously, parallel oil-removal and electrophoresis has been demonstrated using 
a device with surface patterning for oil removal.69 This device contained three extraction 
channels and achieved throughput of 120 samples in 10 min (15 s/sample/channel). This 
sort of parallelization has yet to be applied to newer oil extraction techniques, including 
the density oil drain, which affords easier fabrication. A degree of higher parallelization 
(> 3 simultaneous extraction channels) may also be possible. Up to 384 parallel 
separations have been reported by MCE without oil extraction.25  
A device consisting of just 3 parallel density oil drains and separation channels 
would allow for increased analysis throughput. Using conditions described in Chapter 4, 
a microchip device with three parallel density oil drains would afford a throughput of 21 
min per 384 well plate. Further, a 10,000 compound library could be analyzed within a 
day with just 3 parallel extraction and separation channels.  
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Figure 5-2. Schematic of multi-channel density oil drain device for high-throughput PPI 
modulator screening Three droplet trains can be introduced and electrophoresed 
simultaneously by introduction to three independent separation channels and detecting 
with fluorescence imaging.  
 
Label-Free Protein Cross-linking Capillary Electrophoresis 
An inherent limitation of affinity probe CE-LIF for PPI analysis is the requirement for 
one of the protein binding partners to be fluorescently labeled. Protein labeling is a 
potential source of assay interference as labeling can affect binding affinity.171 Label free 
detection strategies compatible with CE include capacitively coupled contactless 
conductivity, MS, and UV. Use of MS is problematic due to the high concentration of 
SDS in the background electrolyte199 of the SDS-gel electrophoretic separations used in 
this work to readily resolve free proteins from protein complexes. Similarly, the use of 
conductivity detection can be challenging due to electrode fouling.200 Without changing 
separation conditions, UV detection of unlabeled samples is possible due to inherent 
absorbance of peptide bond at 200 nm and aromatic amino acids at 280 nm. To determine 
if PPI analysis of unlabeled protein is possible by CE-UV 3 µM Hsp70 was cross-linked 
injected and separated by capillary gel electrophoresis (Figure 5-3). At this 
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concentration, in the apo nucleotide state, Hsp70 is expected to homodimerize. Both free 
and homodimeric Hsp70 were observed with UV detection, demonstrating the potential 
of label-free PXCE.  
 
 
Figure 5-3. Detection of 3 µM unlabeled Hsp70 using CE-UV. Separation conditions 
were as in Figure 3-9 with the exceptions of the capillary temperature which was 60 ˚C 
and detection method which was UV absorbance at 200 nm.  
 
CE-UV typically suffers from poor limits of detection. In this work, low 
micromolar concentrations of protein were observed to be required for detection. While 
analysis of PPIs with low micromolar Kd values (such as Hsp70 homodimer) is possible, 
the poor sensitivity limits the potential applications of this approach.  
Several possibilities exist for improving CE-UV detection sensitivity. Increasing 
the inner diameter of the capillary increases the path length resulting in linear increase in 
signal. Here a 25 µm internal diameter capillary was employed. Simply increasing the 
internal diameter of the capillary to 50 µm is expected to double the signal. Additional 
sample preconcentration strategies, common in CE201, such as field amplified sample 
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injection and isotachophoresis are compatible with this separation. To demonstrate this 
potential, a combination of field amplified sample injection followed by isotachophoresis, 
termed electrokinetic supercharging, was applied to separation of fluorescently labeled 
Hsp70 (Figure 5-4). A limit of detection of 72 pM was achieved using this method with 
fluorescence detection, suggesting potential to improve sensitivity of CE-UV as well. 
 
Figure 5-4. Separation of 33 nM Hsp70* using electrokinetic supercharging. Sample was 
injected electrokinetically at 9 kV for 30 s. Separation voltage was 400 V/cm. Separation 
distance was 10 cm. The sieving matrix was 7% w/v dextran (1.5-2.8 Mda), 220 mM 
Tris, 180 mM boric acid, 10% glycerol, 13.8 mM SDS, and 3 mM EDTA. 
 
 An alternative to label free detection is to cross-link unlabeled proteins and label 
them after the cross-linking is complete. Proteins could be labeled before separation and 
immediately analyzed by CGE as the unreacted, small molecule fluorophore would be 
readily resolved from the proteins. This puts greater burden on the separation to resolve 
the free fluorophore from both of the free proteins and the protein complex. It also 
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requires the cross-linker and the fluorophore to react with different amino acids. Post-
column labeling could also be employed. Naphthalene-2-3-dicarbaldehyde (NDA) has 
low fluorescence until it conjugates with proteins and has been demonstrated to give low 
nanomolar LODs for CGE of proteins, however this requires modification of the 
background electrolyte202. Alternatively, a non-covalent approach using SYPRO Orange 
dye may be easier to implement. SYPRO Orange dye fluoresces when it associates with 
the hydrophobic core of SDS-protein complexes.169  
Reducing Protein Consumption 
The large amount of protein required for HTS is a significant contributor to the cost of 
screening, particularly for highly sensitive or difficult to produce proteins.203,204. While 
capillary and microchip electrophoresis require only nanoliter to picoliter injection 
volumes current instrumentation requires microliters of sample for injection. For 
example, an ideal injection volume (about 1% of capillary volume) on a 10 cm long, 25 
µm internal diameter capillary, as used in Chapter 3, would be approximately 440 pL. 
However, sample preparation is typically performed on the microliter scale resulting in 
much wasted protein. Performing the sample preparation online has the potential to 
decrease the protein consumption by >100,000-fold in this case.  
One strategy for decreasing protein consumption is to perform the assay within 
the capillary. Many strategies exist for mixing reagent plugs within the capillary for 
performing screening assays online. Mixing strategies include electrophoretically 
mediated microanalysis (EMMA)74,77,79, transverse diffusion of laminar flow profiles 
(TDLFP)80,81 and immobilized enzyme reactors (IMERs)82–87. IMERs is inherently 
incompatible with the PXCE method and while EMMA has been extensively 
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demonstrated on small numbers of compounds, it requires knowledge of electrophoretic 
mobility of each plug. TDLFP is therefore better suited for screening of diverse 
compound libraries. TDLFP exploits the mixing that occurs by parabolic plug flow 
induced by a pressure injection and is therefore mixing is independent of electrophoretic 
mobility. TDLFP has been extensively theoretically and experimentally investigated and 
exhibits good results for mixing of even slowly diffusing molecules such as proteins.88,89 
One study reported sufficient zone overlap of enzyme plug achieved in less than 1 min.89 
The TDLFP strategy has been demonstrated for screening of a limited number of 
compounds for enzyme targets alone80,81,89 but has potential to scale up and apply to PPI 
targets using PXCE with minor modification. This strategy would involve sequentially 
injecting plugs of each protein binding partner and test compound, allowing interactions 
to equilibrate, injecting a plug of cross-linker, and electrophoresing (Figure 5-5). In this 
assay, protein consumption would be reduced to just 300 ng for assaying 10,000 test 
compounds.  
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Figure 5-5. Schematic of online CE assay for PPI screening with mixing by TDLFP for 
PPI screening. Each protein (A and B) and test compound (I) is injected by pressure onto 
capillary inducing parabolic flow and transverse diffusion. Cross-linker (XL) is then 
added by hydrodynamic injection allowing for online protein cross-linking to occur prior 
to electrophoretic separation.  
 
While in-capillary reaction strategies greatly reduce protein consumption to just 
picoliters per sample, the throughput is limited by the kinetics of the reactions performed 
online. For example, an on-chip assay of SIRT1 inhibition by three known inhibitors was 
demonstrated with 10 min of on-chip reaction time.205 With this limitation, the in-
capillary reaction strategy is most well suited for enzyme targets with rapid turnover or 
PPIs where binding occurs rapidly. To assay targets with slower kinetics using this 
strategy capillary array instrumentation is potentially useful. Further, test compound 
sample pooling is also potentially useful to increase throughput. Up to 10 test compounds 
per sample have been analyzed by CE.28 This degree of test compound sample pooling 
would also further reduce protein consumption 10-fold. Test compound sample pooling is 
well suited for PPI screening where low hit rates have been reported. For example, a hit 
rate of just 0.03% was reported for one Hsp90-HOP screen.206  
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Alternatively, the entire assay could be performed in droplets prior to 
electrophoresis. While, the platform described in Chapter 4 introduces only nanoliter 
volumes of sample into the chip the system does not reduce sample requirements as the 
samples are originally prepared and formatted in microliter volumes in a multiwell plate. 
To reduce overall assay volume compound libraries could be reformatted into droplets to 
which protein could be added. There are many reported methods for addition of reagent 
to a sample droplet.46,48,49,63,207,208 With addition of proteins to test compound containing 
droplet, the entire reaction could be performed in the droplet. This strategy has been 
demonstrated with fluorescence70 and MS46 detection. The droplet assay with 
fluorescence detection reported a 25,000-fold reduction in sample compared to bulk 
methods.70 
One challenge with performing the entire assay in droplets is potential for protein 
activity to be impacted by the carrier phase interface The identity of the carrier phase has 
been demonstrated to have an effect on the activity of proteins, in some cases.209 The 
carrier phase used in Chapter 4, silicone oil, is unlikely to be compatible with PPI assays 
due to potential for hydrophobic regions of the protein to adsorb to the oil-droplet 
interface. It is expected that a highly fluorinated carrier phase may be more inert and 
therefore suitable to assaying PPIs within droplets. Use of a heavily fluorinated carrier 
phase would require modification of the density-based oil drain described in Chapter 4 as 
the density of the carrier phase would be greater than the density of most background 
electrolytes. A simple modification to the current design would be to drill a hole through 
the device at the outlet of the fused silica droplet transfer capillary and attach a closed 
reservoir filled with background electrolyte above and below the device. The dense 
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immiscible fluorinated carrier phase would then drain to the bottom of this reservoir 
displacing only about 1 µL of background electrolyte per 100 samples.  
Conclusion 
Challenging method development has hindered analysis of protein-protein interactions by 
capillary electrophoresis. The use of protein cross-linking prior to electrophoresis 
simplifies method development by eliminating the need to maintain the native interaction 
during the separation. Inherent limitations of this strategy include the size and affinities 
of the complexes that can be analyzed in this manner. Nevertheless, this strategy has been 
demonstrated for analysis of eight different protein-protein interactions with micromolar 
to nanomolar Kd values. Separations are readily achieved using capillary or microchip 
electrophoresis and improvements to throughput have allowed separations in 1 min by 
commercial capillary electrophoresis and 2.5 s by microchip electrophoresis. A droplet 
microfluidic method for automated sample introduction for microchip electrophoresis 
achieved sample introduction throughput of 10 s/sample. Potential future work could 
further improve the throughput of sample introduction to microchip electrophoresis, 
modify the method for use with unlabeled protein, and take advantage of the low sample 
volume requirements of capillary electrophoresis.  
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